A method for synthesizing macrocyclic trichothecene toxins

By designing a new synthetic route and utilizing methods such as olefin metathesis and selective oxygen cyclization reactions, compound 7 was synthesized modularly, solving the synthetic challenges of natural products roridin E and verrucarin J. This resulted in an efficient and concise preparation method, promoting the research and application of macrocyclic trichothecene toxins.

CN123106699APending Publication Date: 2026-11-17SHANDONG UNIV
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202611218686.0
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2026-08-12
Publication Date
2026-11-17

AI Technical Summary

Technical Problem

The natural products roridin E and verrucarin J are present in extremely limited quantities, resulting in low extraction and separation efficiency, high costs, and hindering drug activity research and application.

Method used

By designing a new synthetic route, compound 7 was modularly synthesized using olefin metathesis (RCM) reaction, selective oxygen cyclization reaction and Diels-Alder reaction, and verrucarol, roridin E and Verrucarin J were prepared through a series of steps.

Benefits of technology

This study achieved the preparation of verrucarol at the hundred-milligram scale, providing a simple and efficient synthetic method for macrocyclic trichothecene toxins, laying the foundation for subsequent research and applications.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN123106699A_ABST
    Figure CN123106699A_ABST
Patent Text Reader

Abstract

This invention belongs to the field of chemical synthesis technology and relates to a method for synthesizing macrocyclic trichothecene toxins. The method includes steps to obtain compound 7 according to the following reaction route. The synthetic method provided by this invention enables the simple and efficient synthesis of the natural products roridin E and verrucarin J, while simultaneously achieving the preparation of verrucarol at the hundred-milligram scale.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] This invention belongs to the field of chemical synthesis technology and relates to a method for synthesizing macrocyclic trichothecene toxins. Background Technology

[0002] The information disclosed in this background section is intended only to enhance understanding of the overall background of the invention and is not necessarily to be construed as an admission or in any way implying that such information constitutes prior art known to those skilled in the art.

[0003] The natural products roridin E and verrucarin J are macrocyclic trichothecene toxins, primarily produced by various fungi, including *Russula verrucae*. Myrothecium verrucaria ), paper grape spike ( Stachybotrys paper ) and other Fusarium species ( Fusarium Trichoderma () Trichoderma Fungi such as *Caryophyllum serratum* are also found in highly poisonous mushrooms (such as *Caryophyllum serratum*). Podostroma horn-damae Structurally, its core structure consists of a 12,13-epoxy ring and a sesquiterpene skeleton, which is key to its biological activity. It exhibits potent cytotoxicity at the nanomolar or even picomolar levels against various cancer cell lines; for example, it shows high IC50 values ​​against various breast cancer cell lines. 50 With a concentration between 0.02 and 0.05 nM, it can exert broad-spectrum cytotoxicity by inhibiting protein synthesis and also exert targeted antitumor effects by inhibiting specific kinases, making it an important lead compound for anticancer drug development. However, the abundance of these natural products in nature is extremely limited, and the extraction and isolation from fungal ferments is inefficient and costly, thus affecting further research on the drug activity of these natural products and their widespread application. Summary of the Invention

[0004] To address the shortcomings of existing technologies, the present invention aims to provide a method for synthesizing macrocyclic trichothecene toxins. The method provided by the present invention enables the synthesis of natural products roridin E and verrucarin J via a simple and efficient route, while simultaneously achieving the preparation of verrucarol at the hundred-milligram scale.

[0005] To achieve the above objectives, the technical solution of the present invention is as follows: In a first aspect, a method for synthesizing a trichothecene toxin includes the step of obtaining compound 7 according to the following reaction route; ; And the steps for obtaining verrucarol (compound 8) from compound 7 via the following reaction route; .

[0006] In a second aspect, a method for synthesizing macrocyclic trichothecene toxins includes the step of obtaining compound 7 according to the following reaction route; ; And, the steps of obtaining roridin E or Verrucarin J from compound 7 via the following reaction route; .

[0007] According to the above reaction route, compound 7 is a key intermediate in the preparation of verrucarol, roridin E, and Verrucarin J. Therefore, in the third aspect of this invention, an intermediate has the following chemical structure: .

[0008] The beneficial effects of this invention are as follows: This invention redesigned a new synthetic route through structural analysis of verrucarol, roridin E, and Verrucarin J. Key strategies included olefin metathesis (RCM) reaction, selective oxygen cyclization reaction, and Diels-Alder reaction. This invention achieved the modular synthesis of the natural products roridin E and Verrucarin J through the synthesis of the key intermediate 7. Simultaneously, it completed the preparation of verrucarol on a scale of hundreds of milligrams, achieving the largest-scale preparation to date, laying the foundation for subsequent research and applications.

[0009] The synthesis method provided by this invention is simple to operate, has mild conditions, fewer total reaction steps, and high reaction selectivity in each step, resulting in a high overall yield. Detailed Implementation

[0010] It should be noted that the following detailed descriptions are exemplary and intended to provide further illustration of the invention. Unless otherwise specified, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this invention pertains.

[0011] It should be noted that the terminology used herein is for the purpose of describing particular embodiments only and is not intended to limit the scope of exemplary embodiments according to the invention. As used herein, the singular form is intended to include the plural form as well, unless the context clearly indicates otherwise. Furthermore, it should be understood that when the terms "comprising" and / or "including" are used in this specification, they indicate the presence of features, steps, operations, devices, components, and / or combinations thereof.

[0012] TBHP is tert-butyl hydroperoxide; MNBA is 2-methyl-6-nitrobenzoic anhydride; BHT is 2,6-di-tert-butyl-p-cresol; TBAF is tetra-n-butylammonium fluoride; (+)-CSA is (+)-10-camphor sulfonic acid; Oxone is potassium peroxymonosulfonate or potassium peroxymonosulfate (potassium peroxymonosulfate complex salt, 2KHSO5·KHSO4·K2SO4); DIBAl-H is diisobutylaluminum hydride; TBSCl is tert-butyldimethylchlorosilane; PPTS is pyridine p-toluenesulfonate; PivCl is neopentanoyl chloride; DMP is Desmartin periodoyl alkyl; THF is tetrahydrofuran; HMPA is hexamethylphosphoric triamine. p -TSA is p-toluenesulfonic acid; DCC is N,N'-dicyclohexylcarbodiimide; DMAP is 4-dimethylaminopyridine.

[0013] To overcome the problem of insufficient sources of natural product extraction and separation, this invention proposes a method for synthesizing macrocyclic trichothecene toxins.

[0014] A typical embodiment of the present invention provides a method for synthesizing trichothecene toxins, comprising the step of obtaining compound 7 according to the following reaction route; ; And the steps for obtaining verrucarol (compound 8) from compound 7 via the following reaction route; .

[0015] In some embodiments, dichloromethane is used as the solvent in the preparation of compound 1' from compound 1.

[0016] In some embodiments, in step 1) of the process of preparing compound 1', the molar ratio of compound 1 to SeO2 and TBHP is 1:0.25~0.35:0.7~0.9.

[0017] In some embodiments, in step 1) of the process for preparing compound 1', mixing and reaction are carried out at 0-5°C. Specifically, the reaction time is 12-24 hours. In this invention, the 0-5°C condition can be achieved by an ice-water bath.

[0018] In some embodiments, in step 2) of the process for preparing compound 1', mixing and reaction are carried out under anhydrous and oxygen-free conditions. Oxygen-free refers to a non-oxidizing atmosphere, such as a nitrogen atmosphere, an argon atmosphere, etc.

[0019] In some embodiments, in step 2) of the process of preparing compound 1', the molar amount of Me2N=CH2I added is 2.5 to 3.5 times the molar amount of compound 1.

[0020] In some embodiments, in step 2) of the process for preparing compound 1', Et3N is added. Specifically, the molar amount of Et3N added is 2.5 to 3.5 times the molar amount of compound 1.

[0021] In some embodiments, in step 2) of the process for preparing compound 1', the reaction temperature is room temperature and the reaction time is 16-24 hours. Room temperature as described in this invention refers to the temperature of an indoor environment, generally 15-30°C.

[0022] In some embodiments, in step 1) of the process of preparing compound 2 from compound 1', the solvent used is tert-butanol.

[0023] In some embodiments, in step 1) of the process of preparing compound 2 from compound 1', the molar amount of NaClO2 added is 9 to 11 times the molar amount of compound 1'.

[0024] In some embodiments, in step 1) of the process of preparing compound 2 from compound 1', NaH2PO4 is added. Specifically, the molar amount of NaH2PO4 added is 6 to 8 times the molar amount of compound 1'.

[0025] In some embodiments, in step 1) of the process of preparing compound 2 from compound 1', 3-methyl-1-butene is added. Specifically, the molar amount of 3-methyl-1-butene added is 20 to 30 times the molar amount of compound 1'.

[0026] In some embodiments, in step 1) of the process of preparing compound 2 from compound 1', the reaction is carried out at room temperature for 4 to 5 hours.

[0027] In some embodiments, in step 2) of the process of preparing compound 2 from compound 1', the solvent used is a mixed solution of dichloromethane and tetrahydrofuran. Specifically, the volume ratio of dichloromethane to tetrahydrofuran is 1:0.9~1.1.

[0028] In some embodiments, in step 2) of the process of preparing compound 2 from compound 1, mixing and reaction are carried out under anhydrous and oxygen-free conditions.

[0029] In some embodiments, in step 2) of the process of preparing compound 2 from compound 1', the molar amount of MNBA added is 1.8 to 2.2 times the molar amount of compound 1'.

[0030] In some embodiments, in step 2) of the process of preparing compound 2 from compound 1', DMAP is added. Specifically, the molar amount of DMAP added is 1.8 to 2.2 times the molar amount of compound 1'.

[0031] In some embodiments, in step 2) of the process of preparing compound 2 from compound 1, the reaction is carried out at room temperature for 14 to 16 hours.

[0032] In some embodiments, the molar ratio of compound 2 to compound 3 is 1:2.5 to 3.5.

[0033] In some embodiments, BHT is added during the reaction of compound 2 and compound 3 to prepare compound 4. Specifically, the molar ratio of compound 2 to BHT is 1:0.1~0.15.

[0034] In some embodiments, during the reaction of compound 2 and compound 3 to prepare compound 4, the reaction temperature is 175~185 °C and the reaction time is 36~38 hours.

[0035] In some embodiments, toluene is used as the solvent in the reaction of compound 2 and compound 3 to prepare compound 4.

[0036] In some embodiments, the process of preparing compound 5 from compound 4 is as follows: under anhydrous and oxygen-free conditions, compound 4 is first reacted with compound 5 at 0~5°C. i The reaction of Bu2AlH was carried out for 1.4–1.6 hours, and then the resulting product was reacted with TBAF at room temperature for 12.5–13.5 hours. Compound 4 was reacted with… i The solvent for the Bu2AlH reaction is dichloromethane; the solvent for the reaction of the product (diol compound) with TBAF is tetrahydrofuran.

[0037] Specifically, compound 4 and i The molar ratio of Bu2AlH is 1:2.0~3.0.

[0038] Specifically, the molar ratio of the reacted product to TBAF is 1:9~11.

[0039] In some embodiments, compound 5 is reacted with (+)-CSA at room temperature for 8-10 hours under anhydrous and oxygen-free conditions to obtain compound 6.

[0040] In some embodiments, the molar ratio of compound 5 to (+)-CSA is 1:0.09~0.11.

[0041] In some embodiments, in step 1) of the process of preparing compound 7 from compound 6, compound 6 is reacted with KBr and Oxone for 6-8 hours under anhydrous, oxygen-free, and room temperature conditions. Specifically, the solvent in this step is acetonitrile. Specifically, the molar ratio of compound 6, KBr, and Oxone is 1:3.5-4.5:3.5-4.5.

[0042] In some embodiments, in step 2) of the process of preparing compound 7 from compound 6, the product of the reaction in step 1) is reacted with ZnBr2 under anhydrous and oxygen-free conditions and at 0-5°C. n PrSH was mixed, then the mixture was heated to room temperature and reacted for 2-3 hours. Specifically, dichloromethane was used as the solvent in this step. Specifically, the product from the previous reaction was reacted with ZnBr2, n The molar ratio of PrSH is 1:2.7~3.3:5.5~6.5.

[0043] In some embodiments, in step 3) of the process of preparing compound 7 from compound 6, the product of step 2) is mixed uniformly with VO(acac)2 under anhydrous and oxygen-free conditions and at 0-5°C, then TBHP is added, and the mixture is heated to room temperature for 48-50 hours. Specifically, the molar ratio of the product of step 2) to VO(acac)2 and TBHP is 1:0.13-0.17:2.5-3.5. Specifically, the solvent used in this step is dichloromethane.

[0044] In some embodiments, under anhydrous, oxygen-free, and room temperature conditions, compound 7 reacts with zinc powder and NH4Cl at room temperature for 18-20 hours. Specifically, the molar ratio of compound 7 to zinc powder and NH4Cl is 1:15-25:15-25. Specifically, ethanol is used as the solvent in this process.

[0045] A second embodiment of the present invention provides a method for synthesizing macrocyclic trichothecene toxins, comprising the step of obtaining compound 7 according to the following reaction route; ; And, the steps of obtaining roridin E or Verrucarin J from compound 7 via the following reaction route; .

[0046] The process for preparing compound 7 from compound 1 is as described above.

[0047] In some embodiments, compound 7 is first esterified with acrylic anhydride, and then reacted with a zinc-silver complex (Zn-Ag) under anhydrous and oxygen-free conditions under reflux for 12-14 hours to obtain compound 19. Specifically, dichloromethane is used as the solvent in the esterification process. Specifically, the reflux temperature is 53-57°C, and the reflux time is 12-14 hours. Specifically, a mixed solution of tetrahydrofuran, ethanol, and diethyl ether is used as the solvent in the reflux reaction. Specifically, the zinc-silver complex is prepared by heating zinc powder and acetic acid to reflux, then adding AgOAc, and refluxing for 50-70 seconds. The molar ratio of zinc powder to AgOAc is 450-470:1.

[0048] In some embodiments, under anhydrous and oxygen-free conditions, compound 9 is mixed with 2,4,6-trichlorobenzoyl chloride and Et3N at 0–5°C, and then heated to room temperature for 3–4 hours; then cooled to -15–-5°C, compound 19 and DMAP are added, and the mixture is kept at this temperature for 16–18 hours. Specifically, the molar ratio of compound 9, 2,4,6-trichlorobenzoyl chloride, Et3N, compound 19, and DMAP is 1:1.3–1.7:1.3–1.7:0.9–1.1:2.5–3.5.

[0049] In some embodiments, under anhydrous and oxygen-free conditions, compound 20 is reacted with Hoveyda-Grubbs II (Hoveyda-Grubbs second-generation catalyst) at 50-55°C for 3-4 days; then the product is reacted with Et3N and Et3N·3HF at room temperature for 24-26 hours. Specifically, the molar ratio of compound 20, Hoveyda-Grubbs II, Et3N, and Et3N·3HF is 1:0.3-0.7:185-195:190-200.

[0050] In some embodiments, under anhydrous and oxygen-free conditions, compound 10 is mixed with 2,4,6-trichlorobenzoyl chloride and Et3N at 0–5°C, and then heated to room temperature for 3–4 hours; then cooled to -15–-5°C, compound 19 and DMAP are added, and the mixture is kept at this temperature for 16–18 hours. Specifically, the molar ratio of compound 9, 2,4,6-trichlorobenzoyl chloride, Et3N, compound 19, and DMAP is 1:1.3–1.7:1.3–1.7:0.9–1.1:2.5–3.5.

[0051] In some embodiments, under anhydrous and oxygen-free conditions, compound 21 and Hoveyda-Grubbs II are heated to 50-55°C and reacted for 3-4 days. Specifically, the molar ratio of compound 21 to Hoveyda-Grubbs II is 1:0.3-0.7.

[0052] In some embodiments, the method further includes the step of preparing compound 9 according to the following reaction route;

[0053] Specifically, under anhydrous and oxygen-free conditions, compound 11 reacts with TESCl to achieve hydroxyl protection. Then, under anhydrous and oxygen-free conditions and with ZrCp2Cl2 and AlMe3 forming a catalyst, the hydroxyl-protected intermediate is reacted with ethyl chloroformate at room temperature for 12-14 hours to obtain an intermediate product. Next, under anhydrous and oxygen-free conditions and at -80 to -75°C, the intermediate product is mixed with DIBAl-H for 55-65 minutes, and then the temperature is raised to -65 to -55°C for 1.5-2.5 hours to obtain compound 12. More specifically, the molar ratio of compound 11 to TESCl is 1:1.05-1.2. More specifically, the molar ratio of ZrCp2Cl2, AlMe3, the hydroxyl-protected intermediate, and ethyl chloroformate is 1:1.8-2.2:0.9-1.1:1.5-2.5. More specifically, the molar ratio of the intermediate product to DIBAl-H is 1:2.5~3.5.

[0054] Specifically, under anhydrous and oxygen-free conditions at 0–5°C, compound 12 was mixed with imidazole, then TBSCl was added and the mixture was heated to room temperature for 12–14 hours to obtain a silicon-protected intermediate. Under anhydrous and oxygen-free conditions at 0–5°C, the silicon-protected intermediate was reacted with PPTS for 2–3 hours to obtain compound 13. More specifically, the molar ratio of compound 12, imidazole, and TBSCl was 1:2.5–3.5:1.3–1.7. More specifically, the molar ratio of the silicon-protected intermediate to PPTS was 1:0.05–0.1.

[0055] Specifically, under anhydrous and oxygen-free conditions and at -80 to -75°C, compound 13 was added dropwise. n BuLi was heated to room temperature for 4-4.5 hours, then ICH2CO2Na was added and reacted for 48-50 hours to obtain a carboxylic acid intermediate. Under anhydrous and oxygen-free conditions at -80 to -75°C, Et3N and PivCl were added dropwise to the carboxylic acid intermediate, mixed thoroughly, and then heated to room temperature for 55-65 minutes to obtain an activated carboxylic acid intermediate. Under anhydrous and oxygen-free conditions at -80 to -75°C, [the following steps were performed]. n BuLi was added dropwise to the carboxylic acid activation intermediate, mixed under controlled temperature, and then the mixture was gradually heated to room temperature for 12-14 hours to obtain compound 14. The temperature gradient procedure was as follows: first, the temperature was raised to -68 to -72°C and held for 9-11 minutes, then successively increased by 8-12°C and held for 9-11 minutes until reaching 0-2°C, and finally heated to room temperature. More specifically, compound 13... nThe molar ratio of BuLi and ICH2CO2Na is 1:1.05~1.2:1.3~1.7. More specifically, the molar ratio of the carboxylic acid intermediate, Et3N, and PivCl is 1:2.5~3.5:1.5~2.5. More specifically, the molar ratio of the activated carboxylic acid intermediate and... n The molar ratio of Bu to Li is 1:1.01~1.1.

[0056] Specifically, under anhydrous and oxygen-free conditions and at -80 to -75°C, Et3N was added sequentially to compound 14. n After Bu2B·OTf is thoroughly mixed, it is heated to 0~5℃ and reacted for 2~2.2 hours. Then it is cooled to -80~-75℃ and CH3CHO is added dropwise, mixed thoroughly, and then heated to -22~-18℃ and reacted for 14~16 hours to obtain compound 15. More specifically, compound 14, Et3N, n The molar ratio of Bu2B·OTf and CH3CHO is 1:5.5~6.5:4.5~5.5:9~11.

[0057] Specifically, under anhydrous and oxygen-free conditions at 0–5°C, compound 15 was mixed with imidazole and TBSCl, heated to room temperature, and reacted for 14–16 hours to obtain a silicon-protected intermediate. Under anhydrous and oxygen-free conditions at 0–5°C, NaBH4 solution was added dropwise to the silicon-protected intermediate, and the mixture was heated to room temperature and reacted for 14–16 hours to obtain a hydroxyl intermediate. Under anhydrous and oxygen-free conditions at 0–5°C, the hydroxyl intermediate was mixed with NaHCO3 and DMP, and the mixture was heated to room temperature and reacted for 3–4 hours to obtain compound 16. More specifically, the molar ratio of compound 15 to imidazole and TBSCl was 1:4.5–5.5:2.5–3.5. More specifically, the molar ratio of the silicon-protected intermediate to NaBH4 was 1:4.5–5.5. More specifically, the molar ratio of the hydroxyl intermediate, NaHCO3, and DMP was 1:4.5–5.5:2.5–3.5.

[0058] Specifically, under anhydrous and oxygen-free conditions and at -80 to -75°C, diethyl allylphosphonate was added dropwise. n BuLi, then add compound 16 and HMPA, mix for 110-130 minutes, heat to room temperature and react for 14-16 hours to obtain compound 17. More specifically, compound 16, HMPA, diethyl allylphosphonate, n The molar ratio of Bu to Li is 1:1.5~2.0:1.8~2.2:1.4~1.6.

[0059] Specifically, under anhydrous and oxygen-free conditions at 0–5°C, compound 17 is reacted with p-toluenesulfonic acid for 2–3 hours to obtain a desilication intermediate; under anhydrous and oxygen-free conditions at 0–5°C, the desilication intermediate is mixed with NaHCO3 and DMP, and the mixture is heated to room temperature for 1–1.5 hours to obtain an aldehyde intermediate; under anhydrous and oxygen-free conditions at room temperature, the aldehyde intermediate is mixed with 3-methyl-1-butene, NaClO2, and NaH2PO4, and the mixture is reacted for 4–5 hours to obtain compound 9. More specifically, the molar ratio of compound 17 to toluenesulfonic acid is 1:0.14–0.16. More specifically, the molar ratio of the desilication intermediate, NaHCO3, and DMP is 1:5.5–6.5:3.5–4.5. More specifically, the molar ratio of the aldehyde intermediate, 3-methyl-1-butene, NaClO2, and NaH2PO4 is 1:20~30:8~12:6.8~7.2.

[0060] In some embodiments, the method further includes the step of preparing compound 10 according to the following reaction route;

[0061] Specifically, under anhydrous, oxygen-free, and room temperature conditions, compound 13 was mixed with DCC, DMAP, and 2,4-pentadienoic acid, and reacted for 14–16 hours to obtain compound 18. More specifically, the molar ratio of compound 13, DCC, DMAP, and 2,4-pentadienoic acid was 1:1.8–2.2:0.1–0.3:1.01–1.1.

[0062] Specifically, under anhydrous, oxygen-free, and room temperature conditions, compound 18 was mixed with TBAF and reacted for 2-3 hours to obtain a desilication intermediate; under anhydrous, oxygen-free, and 0-5°C conditions, the desilication intermediate was mixed with NaHCO3 and DMP, and reacted at room temperature for 2-3 hours to obtain an aldehyde intermediate; under anhydrous, oxygen-free, and room temperature conditions, the aldehyde intermediate was mixed with 3-methyl-1-butene, NaClO2, and NaH2PO4, and reacted for 4-5 hours to obtain compound 10. More specifically, the molar ratio of compound 18 to TBAF was 1:3.5-4.5. More specifically, the molar ratio of the desilication intermediate, NaHCO3, and DMP was 1:5.5-6.5:3.5-4.5. More specifically, the molar ratio of the aldehyde intermediate, 3-methyl-1-butene, NaClO2, and NaH2PO4 is 1:20~30:8~12:6.8~7.2.

[0063] A third embodiment of the present invention provides an intermediate with the following chemical structure: .

[0064] To enable those skilled in the art to better understand the technical solution of the present invention, the technical solution of the present invention will be described in detail below with reference to specific embodiments.

[0065] The synthesis process of raw material compound 1 in Example 1 is as follows:

[0066] Compound S1 is a known compound.

[0067] In a flame-dried flask, alcohol S1 (1.5 g, 8.24 mmol, 1.0 equivalent) and dichloromethane (82 mL) were added. DIPEA (11.48 mL, 65.92 mmol, 8.0 equivalent) was then added with stirring at room temperature, and the mixture was stirred at the same temperature for 10 min. After 10 min, MOMBr (4.04 mL, 49.44 mmol, 6.0 equivalent) was slowly added dropwise to the reaction mixture, and the reaction was heated to 40 °C and stirred for 12 h. The reaction progress was monitored by TLC. After the reaction was complete, the mixture was cooled to room temperature and quenched with 20 mL of water. The aqueous layer was extracted with dichloromethane (30 mL × 3). The combined organic phases were washed with brine (50 mL), dried over sodium sulfate, filtered, concentrated, and purified by rapid column chromatography (petroleum ether / ethyl acetate = 6 / 1) to give compound S2 (1.58 g, 85%) as a colorless oil.

[0068] Data for compound S2: 1 H NMR (400 MHz, CDCl3) δ 4.89 (d, J = 7.8 Hz, 1H), 4.61 (d, J = 6.8 Hz, 1H), 4.51 (d, J = 6.8 Hz, 1H), 3.93 (s, 1H), 3.26 (s, 3H), 2.36 – 2.23 (m, 1H), 2.17 – 1.94 (m, 4H), 1.81 (dd, J = 12.3, 10.1, 6.7 Hz, 1H), 1.58 (s, 3H), 1.49 (s, 3H), 0.89 (s, 3H). 13 C NMR (100 MHz, CDCl3) δ 134.53, 118.94, 95.59, 79.94, 55.33, 53.15, 35.14, 33.75, 25.83, 25.55, 17.74, 16.09.

[0069] The flame-dried flask was purged three times with argon. Potassium tert-butoxide (2.49 g, 22.18 mmol, 2.6 equivalents), Ph3P=CH2 (7.92 g, 22.18 mmol, 2.6 equivalents), and THF (30 mL) were added sequentially to the reaction flask in one continuous addition. The mixture was stirred at room temperature for 2 hours, during which time the solution turned yellow. After 2 hours, compound S2 (1.93 g, 8.53 mmol, 1.0 equivalent) was dissolved in 20 mL of THF and transferred to the reaction flask using a syringe. The solution immediately turned orange-red and was stirred at room temperature for 12 hours. The reaction progress was monitored by TLC. After the reaction was complete, it was quenched with saturated NH4Cl (30 mL) and extracted with ethyl acetate (40 mL × 3). The combined organic phases were washed with brine (50 mL), dried over sodium sulfate, filtered, concentrated, and purified by rapid column chromatography (petroleum ether / ethyl acetate = 80 / 1) to give compound S3 (1.69 g, 88%) as a colorless oil.

[0070] Data for compound S3: 1 H NMR (400 MHz, CDCl3) δ 5.07 (s, 1H), 4.84 (s, 1H), 4.72 (s, 1H), 4.62 (d, J = 6.6 Hz, 1H), 4.53 (d, J = 6.7 Hz, 1H), 3.72 (s, 1H), 3.30 (s, 3H), 2.41 (dddd, J = 16.0, 8.9, 4.6, 2.2 Hz, 1H), 2.28 – 2.16 (m, 1H), 2.02 (dd, J =10.9, 7.5 Hz, 2H), 1.95 – 1.84 (m, 1H), 1.64 (s, 3H), 1.61 (s, 1H), 1.54 (s, 3H), 0.98 (s, 3H). 13 C NMR(100 MHz, CDCl3) δ 157.40, 133.04, 120.90, 105.26, 95.87,83.61, 55.32, 49.11, 37.52, 29.25, 28.43, 26.06, 21.20, 18.06.

[0071] In a flame-dried flask, substrate S3 (3.39 g, 15.12 mmol, 1.0 equivalent) was transferred to the flask with 100 mL of dichloromethane. The mixture was placed at 0 °C. After 5 minutes, solid NaHCO3 (6.43 g, 75.6 mmol, 5.0 equivalent) was added in one go, and the mixture was stirred at 0 °C for 10 minutes. After 10 minutes, m-chloroperoxybenzoic acid (…) was added. m -CPBA (5.22 g, 22.68 mmol, 1.5 equivalents). The reaction was carried out at 0 °C for 2 h. The reaction progress was monitored by TLC. After the reaction was complete, the reaction was quenched with saturated sodium thiosulfate aqueous solution (30 mL) and extracted with dichloromethane (60 mL × 3). The combined organic phases were washed with brine (50 mL) and sodium carbonate aqueous solution (30 mL), dried over sodium sulfate, filtered, and concentrated to give crude compound S4.

[0072] In a flame-dried flask, crude compound S4 was transferred to the flask with 40 mL of diethyl ether. The mixture was placed at 0 °C. After 5 minutes, H5IO6 (6.89 g, 30.24 mmol, 2.0 equivalent) was dissolved in 10 mL of THF (ultrasonic dissolution), and this solution was transferred to the flask using a syringe. The reaction was carried out at 0 °C for 1.5 h. The reaction progress was monitored by TLC. After the reaction was complete, the mixture was quenched with water (20 mL), and the organic layer was extracted with ethyl acetate (30 mL × 3). The combined organic phases were washed with brine (50 mL), dried over sodium sulfate, filtered, concentrated, and purified by rapid column chromatography (petroleum ether / ethyl acetate = 10 / 1) to give compound 1 (1.60 g, 53%) as a colorless oil.

[0073] Data for compound 1: 1 H NMR (400 MHz, CDCl3) δ 9.77 (s, 1H), 4.94 (s, 1H), 4.83 (s, 1H), 4.70 – 4.55 (m, 2H), 3.86 (s, 1H), 3.34 (s, 3H), 2.59 – 2.45 (m, 2H), 2.46 –2.27 (m, 2H), 2.04 (dddd, J = 12.6, 9.1, 6.1, 3.6 Hz, 1H), 1.76 – 1.63 (m, 1H), 1.14 (s, 3H). 13C NMR (100 MHz, CDCl3) δ 202.99, 155.80, 106.69, 96.04, 83.48, 55.67,51.93, 47.08, 28.45, 27.82, 21.61. Example 1: Preparation of compound verrucarol The synthetic route for the compound verrucarol is shown below:

[0074] Synthesis of Compound 2

[0075] In a flame-dried flask, SeO2 (538 mg, 4.85 mmol, 0.3 equivalents) was transferred to the flask with 55 mL of dichloromethane. The mixture was placed at 0 °C. After 5 minutes, TBHP (2.35 mL, 5.5 M hexane solution, 12.92 mmol, 0.8 equivalents) was transferred to the flask using a syringe. The reaction was continued to be stirred at 0 °C for 0.5 hours. After 0.5 hours, compound 1 (3.20 g, 16.15 mmol, 1.0 equivalents) was transferred to the flask with 25 mL of dichloromethane, and the mixture was stirred at room temperature for 12 hours. The reaction progress was monitored by TLC. After the reaction was complete, the mixture was quenched with an aqueous sodium thiosulfate solution (20 mL), and the organic phase was extracted with dichloromethane (50 mL × 3). The combined organic phases were washed with brine (50 mL), dried over sodium sulfate, filtered, and concentrated. The crude product was used directly in the next reaction without further purification.

[0076] The flame-dried flask was purged three times with argon. The substrate obtained in the previous step was transferred to the flask with 50 mL of dichloromethane. Et3N (6.73 mL, 48.45 mmol, 3.0 equivalent) and Me2N=CH2I (8.96 g, 48.45 mmol, 3.0 equivalent) were added sequentially to the flask. The reaction was stirred at room temperature for 16 hours. After 16 hours, the reaction progress was monitored by TLC. After the reaction was complete, it was quenched with an aqueous sodium bicarbonate solution (20 mL), and the organic phase was extracted with dichloromethane (40 mL × 3). The combined organic phases were washed with brine (50 mL), dried over sodium sulfate, filtered, concentrated, and purified by rapid column chromatography (petroleum ether / ethyl acetate = 7 / 1) to give the compound enal (compound 1', 1.18 g, yield 32.2%).

[0077] In a flame-dried flask, the above-mentioned enal (928 mg, 4.10 mmol, 1.0 equivalent) was transferred to the flask with 30 mL of tert-butanol. With stirring, 3-methyl-1-butene (11.46 mL, 102.5 mmol, 25.0 equivalent) was added to the flask. Separately, in a clean 50 mL reaction vial, NaClO2 (4.64 g, 41.0 mmol, 10.0 equivalent) and NaH2PO4 (3.44 g, 28.7 mmol, 7.0 equivalent) were weighed and placed inside, and water (10 mL) was added and dissolved by sonication. This aqueous solution was then added to the reaction mixture. The reaction was stirred at room temperature for 4 hours. After 4 hours, the reaction progress was monitored by TLC. After the reaction was complete, the mixture was quenched with water (20 mL), and the organic phase was extracted with ethyl acetate (40 mL × 3). The combined organic phases were washed with brine (50 mL), dried over sodium sulfate, filtered, and concentrated to obtain crude acid.

[0078] The flame-dried flask was purged three times with argon. MNBA (2.82 g, 8.20 mmol, 2.0 equivalent) was added to a 500 mL side-mount flask, followed by 400 mL of dichloromethane. With stirring, the crude acid and DMAP (1.0 g, 8.20 mmol, 2.0 equivalent) were dissolved in 21 mL of dichloromethane and 21 mL of THF, and this solution was slowly added dropwise to the flask. The reaction was stirred at room temperature for 14 hours. After 14 hours, the reaction progress was monitored by TLC. After the reaction was complete, the mixture was quenched with water (20 mL) and concentrated to remove the solvent. The organic phase was extracted with dichloromethane (30 mL × 3). The combined organic phases were washed with brine (50 mL), dried over sodium sulfate, filtered, concentrated, and purified by rapid column chromatography (petroleum ether / ethyl acetate = 5 / 1) to give compound 2 (597 mg, 65% yield).

[0079] Data for compound 2: 1 H NMR (400 MHz, CDCl3) δ 6.45 (s, 1H), 5.72 (s, 1H), 5.32 (s, 1H), 5.09 (s, 1H), 4.94 (d, J = 5.8 Hz, 1H), 4.65 – 4.49 (m, 2H), 3.87 (dd, J = 6.8,1.9 Hz, 1H), 3.33 (s, 3H), 2.57 (dd, J = 16.1, 6.7 Hz, 1H), 2.11 (ddd, J= 16.1,5.9, 1.8 Hz, 1H), 1.41 (s, 3H). 13 C NMR (100 MHz, CDCl3) δ 164.27, 149.25, 143.82, 126.27, 108.79, 95.65, 81.81, 80.36, 55.83, 51.48, 41.72, 14.20. Synthesis of Compound 4

[0080] In a glove box, dienophile 2 (1.125 g, 5.02 mmol, 1.0 equivalent), dienophile 3 (2.984 g, 15.0599 mmol, 3.0 equivalent), BHT (122 mg, 0.5522 mmol, 0.11 equivalent), and toluene (40 mL) were added sequentially to a flame-dried 100 mL sealed tube. The tube was then capped and heated at 180 °C for 36 hours. The reaction progress was monitored by TLC after 36 hours. Upon completion of the reaction, the mixture was concentrated directly under reduced pressure and purified by rapid column chromatography (petroleum ether / ethyl acetate = 1 1 / 1) to give compound 4 (1.45 g, yield 68.6%) and compound C11. -iso -4 (207 mg, yield 9.8%).

[0081] Data for compound 4: 1 H NMR(400 MHz, CDCl3) δ 5.33 (t, J = 1.7 Hz, 1H), 5.28 (s, 1H), 5.08– 5.03 (m, 1H), 5.02 (s, 1H), 4.83 (d, J = 6.0 Hz, 1H), 4.64 – 4.52 (m, 2H), 4.35 (dd, J = 6.6, 1.3 Hz, 1H), 3.34 (s, 3H), 2.45 – 2.35 (m, 1H), 2.12 (d, J= 14.5 Hz, 2H), 2.02 (d, J = 10.9 Hz, 3H), 1.71 – 1.63 (m, 3H), 1.36 (s, 3H), 0.87 (s, 9H), 0.04 (s, 3H), -0.05 (s, 3H). 13C NMR(100 MHz, CDCl3) δ 176.42, 150.84, 132.78, 128.20, 109.63,95.25, 80.48, 77.02, 76.49, 56.45, 55.73, 49.93, 41.42, 30.50, 28.15, 26.15,22.69, 18.14, 15.80, -4.01, -5.16. Synthesis of Compound 5

[0082] The flame-dried flask was purged three times with argon. Substrate 4 (503 mg, 1.19 mmol, 1.0 equivalent) was dissolved in dichloromethane (12 mL), and the reaction flask was cooled to 0 °C. The flask was then slowly added dropwise at 0 °C. i Bu₂AlH (2.38 mL, 1.5 M toluene solution, 3.57 mmol, 3.0 equivalent). The mixture was then stirred at 0 °C for 1.5 h. After 1.5 h, the reaction progress was monitored by TLC. After the reaction was complete, the reaction was quenched by slow addition of potassium sodium tartrate solution at 0 °C, and the mixture was stirred at room temperature for 3 h. The organic phase was then extracted with dichloromethane (20 mL × 3). The combined organic phases were washed with brine (50 mL), dried over sodium sulfate, filtered, and concentrated to give crude diol.

[0083] The flame-dried flask was purged three times with argon. The crude diol was dissolved in tetrahydrofuran (10 mL). TBAF (11.9 mL, 1 M THF solution, 11.9 mmol, 10.0 equivalent) was then added to the reaction flask, and the mixture was stirred at room temperature for 12 hours. After 12 hours, the reaction progress was monitored by TLC. After the reaction was complete, a saturated ammonium chloride solution (20 mL) was added to quench the reaction, and the organic phase was extracted with ethyl acetate (30 mL × 3). The combined organic phases were washed with brine (50 mL), dried over sodium sulfate, filtered, concentrated, and purified by rapid column chromatography (petroleum ether / ethyl acetate = 1 / 2) to give compound 5 (256 mg, 69% yield).

[0084] Data for compound 5: 1 H NMR (400 MHz, CDCl3) δ 5.65 (d, J = 5.7 Hz, 1H), 5.32 (s, 1H), 5.02(s, 1H), 4.85 – 4.72 (m, 3H), 4.55 (d, J= 5.8 Hz, 1H), 4.26 (d, J = 4.7 Hz, 1H), 4.20 (s, 1H), 4.11 (d, J = 7.2 Hz, 1H), 3.72 (d, J = 12.5 Hz, 1H), 3.54 (d, J =13.2 Hz, 1H), 3.41 (s, 3H), 2.36 (dd, J = 12.7, 6.2 Hz, 1H), 2.13 – 1.93 (m,4H), 1.74 (dd, J = 11.3, 4.8 Hz, 1H), 1.68 (s, 3H), 1.65 – 1.57 (m, 2H), 1.13(s, 3H). 13 C NMR(100 MHz, CDCl3) δ 159.37, 138.11, 123.00, 115.03, 95.61,79.18, 75.74, 67.41, 63.52, 56.71, 50.94, 46.41, 38.16, 28.58, 23.11, 21.02,14.31. Synthesis of Compound 6

[0085] The mixture was purged three times with argon in a flame-dried flask. Substrate 5 (1.69 g, 5.41 mmol, 1.0 equivalent) was dissolved in dichloromethane (54 mL). Then, (+)-CSA (125 mg, 0.54 mmol, 0.1 equivalent) was added to the reaction flask, and the solution was stirred at room temperature for 8 hours. After 8 hours, the reaction progress was monitored by TLC. After the reaction was complete, the reaction was quenched with saturated sodium bicarbonate aqueous solution (24 mL), and the organic phase was extracted with dichloromethane (40 mL × 3). The combined organic phases were washed with brine (50 mL), dried over sodium sulfate, filtered, concentrated, and purified by rapid column chromatography (petroleum ether / ethyl acetate = 2 / 1) to give compound 6 (1.13 g, 71% yield).

[0086] Data for compound 6: 1 H NMR (400 MHz, CDCl3) δ 5.39 (d, J= 5.6 Hz, 1H), 5.10 (s, 1H), 4.72 –4.57 (m, 4H), 4.39 (d, J = 5.2 Hz, 1H), 3.77 (d, J = 11.9 Hz, 1H), 3.69 (d, J = 6.0Hz, 1H), 3.58 (d, J = 11.9 Hz, 1H), 3.36 (s, 3H), 2.45 (m, 1H), 1.99 (d, J = 9.8Hz, 2H), 1.93 – 1.82 (m, 1H), 1.82 – 1.70 (m, 1H), 1.67 (s, 3H), 1.59 – 1.48(m, 2H), 1.16 (s, 3H). 13 C NMR(100 MHz, CDCl3) δ 153.08, 140.68, 119.23, 105.05, 95.55,78.97, 77.76, 66.68, 63.32, 55.65, 52.15, 44.03, 38.51, 28.39, 23.44, 20.17,11.83. Synthesis of Compound 7

[0087] The mixture was purged three times with argon in a flame-dried flask. Substrate 6 (267 mg, 0.91 mmol, 1.0 equivalent) was dissolved in acetonitrile (18 mL). KBr (433 mg, 3.64 mmol, 4.0 equivalent) and Oxone (1.26 g, 3.64 mmol, 4.0 equivalent) were then added to the reaction flask, and the solution was stirred at room temperature for 6 hours. The reaction progress was monitored by TLC after 6 hours. After the reaction was complete, a saturated aqueous sodium sulfite solution (10 mL) was added to quench the reaction mixture, and the organic phase was extracted with ethyl acetate (10 mL × 3). The combined organic phases were washed with brine (50 mL), dried over sodium sulfate, filtered, and concentrated to obtain the crude product.

[0088] The flame-dried flask was purged three times with argon. The crude product was dissolved in dichloromethane (14 mL). The reaction flask was cooled to 0 °C, and then ZnBr2 (615 mg, 2.73 mmol, 3.0 equivalent) was added. nPrSH (0.25 mL, 2.73 mmol, 6.0 equivalence). The solution was brought to room temperature and stirred at room temperature for 2 hours. After 2 hours, the reaction progress was monitored by TLC. After the reaction was complete, the reaction was quenched by adding saturated sodium bicarbonate aqueous solution (6 mL) and the mixture was stirred for 3 hours. The organic phase was then extracted with dichloromethane (20 mL × 3). The combined organic phases were washed with brine (50 mL), dried over sodium sulfate, filtered, concentrated, and purified by rapid column chromatography (petroleum ether / ethyl acetate = 1 / 1) to give the de-MOM product (224 mg, yield 75%).

[0089] The reaction mixture was purged three times with argon in a flame-dried flask. The de-MOM product (256 mg, 0.78 mmol, 1.0 equivalent) was dissolved in dichloromethane (8 mL). The reaction flask was cooled to 0 °C, VO(acac)₂ (32 mg, 0.12 mmol, 0.15 equivalent) was added, and the mixture was stirred at 0 °C for 10 min. After 10 min, TBHP (0.43 mL, 5.5 M hexane solution, 2.34 mmol, 3.0 equivalent) was added. The solution was brought to room temperature and stirred at room temperature for 2 days. After 2 days, the reaction progress was monitored by TLC. After the reaction was complete, the reaction mixture was quenched with saturated sodium thiosulfate aqueous solution (6 mL), and stirred for 3 h. The organic phase was then extracted with dichloromethane (20 mL × 3). The combined organic phases were washed with brine (50 mL), dried over sodium sulfate, filtered, concentrated, and purified by rapid column chromatography (petroleum ether / ethyl acetate = 1 / 1) to give compound 7 (174 mg, yield 65%).

[0090] Data for compound 7: 1 H NMR (400 MHz, CDCl3) δ 4.28 (dd, J = 7.6, 3.3 Hz, 1H), 4.22 – 4.13 (m,1H), 3.91 (d, J = 5.2 Hz, 1H), 3.71 (d, J = 15.2 Hz, 3H), 3.08 (d, J = 3.9 Hz, 1H), 2.72 (d, J = 3.9 Hz, 1H), 2.57 (dd, J = 15.7, 7.4 Hz, 1H), 2.16 (dd, J= 13.9, 10.3Hz, 1H), 2.04 – 1.85 (m, 2H), 1.80 – 1.66 (m, 1H), 1.50 (td, J = 11.0, 2.5 Hz,1H), 1.23 (s, 3H), 0.66 (s, 3H). 13 C NMR(100 MHz, CDCl3) δ 79.53, 73.59, 73.02, 67.73, 66.08, 65.07,54.42, 46.97, 46.39, 40.55, 40.06, 27.82, 24.35, 18.98, 6.33. Synthesis of compound verrucarol (8)

[0091] The flame-dried flask was purged three times with argon. Bromine-containing substrate 7 (885 mg, 2.5722 mmol, 1.0 equivalent) was dissolved in ethanol (26 mL). Then, with stirring, zinc powder (3.363 g, 51.444 mmol, 20.0 equivalent) and NH4Cl (2.752 g, 51.444 mmol, 20.0 equivalent) were added to the above reaction flask. The reaction mixture was stirred at room temperature for 18 hours. After 18 hours, the reaction progress was monitored by thin-layer chromatography. After the reaction was complete, the mixture was filtered directly through diatomaceous earth and a silica gel pad and washed with ethyl acetate (60 mL). The organic layers were combined, concentrated, and purified by rapid column chromatography (dichloromethane / methanol = 50 / 1) to give verrucarol (8) (534 mg, 78%) as a white solid.

[0092] Data for compound verrucarol (8): 1H NMR (400 MHz, CDCl3) δ 5.43 - 5.41 (m, 1H), 4.62 (m, 1H), 3.80 (d, J= 5.3 Hz, 1H), 3.74 (dd, J = 11.9, 4.1 Hz, 1H), 3.62 (d, J = 5.7 Hz, 1H), 3.55 (dd, J = 11.8, 4.9 Hz, 1H), 3.10 (d, J = 3.9 Hz, 1H), 2.80 (d, J = 3.9Hz, 1H), 2.56 (dd, J = 15.7, 7.6 Hz, 1H), 2.04 – 1.86 (m, 5H), 1.74 – 1.71(m, 2H), 1.71 (s, 3H), 0.93 (s, 3H). 13 C NMR(100 MHz, CDCl3) δ 141.08, 118.89, 78.80, 74.57, 66.68, 65.88,62.56, 49.09, 47.78, 44.00, 39.97, 28.35, 23.39, 21.12, 7.36. Example 2 Preparation of compound roridin E I. Preparation of the branched compound 9: The synthetic route for compound 9 is shown below:

[0093] Synthesis of Compound 12

[0094] The flame-dried flask was purged three times with argon. Substrate 11 (6.8 mL, 89.8844 mmol, 1.0 equivalent) was dissolved in dichloromethane (80 mL), and the reaction flask was cooled to 0 °C. Imidazole (12 g, 176.1734 mmol, 1.96 equivalent) was added at 0 °C, and the mixture was stirred at 0 °C for 0.5 h. After 0.5 h, TESCl (16.59 mL, 98.8728 mmol, 1.1 equivalent) was slowly added dropwise. The reaction flask was slowly brought to room temperature and stirred for 12 h. After 12 h, the reaction was quenched with saturated ammonium chloride solution (15 mL). The organic phase was then extracted with dichloromethane (30 mL × 3). The combined organic phases were washed with brine (50 mL), dried over sodium sulfate, filtered, and concentrated. The product was used directly in the next reaction without further purification to give a silane-protected product (16.05 g, 97%).

[0095] The flask was purged three times with argon gas in a flame-dried flask. ZrCp₂Cl₂ (4.76 g, 16.29 mmol, 1.0 equivalent) was placed in dichloromethane (40 mL). AlMe₃ (16.3 mL, 2.0 M hexane solution, 32.58 mmol, 2.0 equivalent) was then slowly added to the flask with stirring at room temperature for 4 hours. After 4 hours, the above-mentioned silane-protected product (3.0 g, 16.29 mmol, 1.0 equivalent) was dissolved in dichloromethane (4 mL) and slowly added dropwise to the reaction flask. The mixture was stirred at room temperature for 2 days. After 2 days, the reaction flask was cooled to 0 °C, and ethyl chloroformate (3.1 mL, 32.58 mmol, 2.0 equivalent) was slowly added dropwise. The reaction flask was then stirred at room temperature for 12 hours. After 12 hours, the reaction flask was cooled to 0 °C again, and water (8 mL) was slowly added to quench the reaction. The mixture was stirred at room temperature for 5 hours. Five hours later, the reaction mixture was filtered through a diatomaceous earth pad, washed with petroleum ether, and concentrated by rotary evaporation. The organic phase was then extracted with dichloromethane (16 mL × 3). The combined organic phases were washed with brine (50 mL), dried over sodium sulfate, filtered, and concentrated. The resulting product was used directly in the next reaction without further purification.

[0096] The flame-dried flask was purged three times with argon. The substrate obtained in the previous step was placed in tetrahydrofuran (77 mL), and the reaction flask was cooled to -78 °C. DIBAl-H (32.58 mL, 1.5 M toluene solution, 48.87 mmol, 3.0 equivalence) was slowly added at -78 °C. The mixture was then stirred at -78 °C for 1 hour. After 1 hour, the temperature was adjusted to -60 °C and stirring was continued for 2 hours. After 2 hours, the reaction progress was monitored by TLC. After the reaction was complete, the reaction was quenched by slowly adding potassium sodium tartrate solution (35 mL), and the mixture was stirred at room temperature for 3 hours. The organic phase was then extracted with ethyl acetate (55 mL × 3). The combined organic phases were washed with brine (70 mL), dried over sodium sulfate, filtered, concentrated, and purified by rapid column chromatography (petroleum ether / ethyl acetate = 3 / 1) to give compound 12 (1.5 g, 40% yield).

[0097] Data for compound 12: 1 H NMR (400 MHz, CDCl3) δ 5.37 (s, 1H), 4.07 (d, J = 6.9 Hz, 2H), 3.64(dd, J= 8.3, 5.9 Hz, 2H), 2.34 (s, 1H), 2.20 (t, J = 7.2 Hz, 2H), 1.63 (s, 3H), 0.90 (td, J = 8.1, 2.5 Hz, 9H), 0.55 (dd, J = 8.1, 2.5 Hz, 7H). 13 C NMR (100 MHz, CDCl3) δ 136.14, 125.48, 61.80, 59.07, 42.80, 16.66, 6.76, 4.38. Synthesis of Compound 13

[0098] The mixture was purged three times with argon in a flame-dried flask. Substrate 12 (1.32 g, 5.73 mmol, 1.0 equivalent) was dissolved in dichloromethane (270 mL), and the flask was cooled to 0 °C. Imidazole (1.17 g, 17.19 mmol, 3.0 equivalent) was added at 0 °C. The mixture was stirred at 0 °C for 0.5 h. After 0.5 h, TBSCl (1.30 g, 8.60 mmol, 1.5 equivalent) dissolved in dichloromethane (17 mL) was slowly added dropwise to the reaction mixture. The mixture was then brought to room temperature and stirred for 12 h. After 12 h, the reaction progress was monitored by thin-layer chromatography. After the reaction was complete, the reaction was quenched by slowly adding saturated ammonium chloride aqueous solution (20 mL). The organic phase was extracted with dichloromethane (75 mL × 3). The combined organic phases were washed with brine (60 mL), dried over sodium sulfate, filtered, concentrated, and purified by rapid column chromatography (petroleum ether / ethyl acetate = 10 / 1) to give a silane-based protected compound (1.74 g, yield 88%) as a colorless oily liquid.

[0099] The reaction mixture was purged three times with argon in a flame-dried flask. The aforementioned silicon-based protecting compound (2.02 g, 5.87 mmol, 1.0 equivalent) was dissolved in dichloromethane (140 mL) and methanol (140 mL), and the flask was cooled to 0 °C. PPTS (103 mg, 0.41 mmol, 0.07 equivalent) was dissolved in dichloromethane (6 mL) and methanol (6 mL), and then slowly added dropwise to the reaction flask at 0 °C. The reaction mixture was maintained at 0 °C and stirred for 2 hours. After 2 hours, the reaction progress was monitored by thin-layer chromatography. Once the reaction was complete, a saturated aqueous solution of sodium bicarbonate (40 mL) was slowly added at 0 °C to quench the reaction. The reaction mixture was first concentrated to remove methanol, and the remaining aqueous phase was extracted with dichloromethane (45 mL × 3). The combined organic phases were washed with brine (50 mL), dried over sodium sulfate, filtered, concentrated, and purified by rapid column chromatography (petroleum ether / ethyl acetate = 5 / 1) to give compound 13 (1.07 g, yield 79%).

[0100] Data for compound 13: 1 H NMR (400 MHz, CDCl3) δ 5.38 (t, J = 6.5 Hz, 1H), 4.18 (d, J = 6.4 Hz, 2H), 3.66 (td, J = 6.5, 2.1 Hz, 2H), 2.24 (t, J = 6.5 Hz, 2H), 2.01 (s, 1H), 1.64 (s, 3H), 0.88 (s, 9H), 0.06 (s, 6H). 13 C NMR(100 MHz, CDCl3) δ 133.70, 127.28, 60.29, 60.18, 42.61, 26.09,18.51, 16.30, -5.01. Synthesis of Compound 14

[0101] The mixture was purged three times with argon in a flame-dried flask. Substrate 13 (733 mg, 3.18 mmol, 1.0 equivalent) was dissolved in tetrahydrofuran (20 mL), and the reaction flask was cooled to -78 °C. After 10 minutes, the mixture was slowly added dropwise at -78 °C. nBuLi (2.2 mL, 1.6 M THF solution, 3.50 mmol, 1.1 equivalents). The mixture was then brought to room temperature and stirred for 4 hours. After 4 hours, ICH2CO2Na (992 mg, 4.77 mmol, 1.5 equivalents) was added in a single batch, the flask was wrapped with aluminum foil, and stirred at room temperature for 48 hours. After 48 hours, the reaction progress was monitored by thin-layer chromatography. After the reaction was complete, 20 mL of saturated NH4Cl aqueous solution was added to quench the reaction. The organic phase was extracted with ethyl acetate (30 mL × 3). The combined organic phases were washed with brine (50 mL), dried over sodium sulfate, filtered, concentrated, and purified by rapid column chromatography (petroleum ether / ethyl acetate = 2 / 1) to give the product carboxylic acid (788 mg, yield 86%) as a colorless oily liquid.

[0102] The reaction vessel was purged three times with argon in a flame-dried flask. The above carboxylic acid (327 mg, 1.13 mmol, 1.0 equivalent) was dissolved in tetrahydrofuran (11 mL), and the flask was cooled to -78 °C. After 10 minutes, Et3N (0.47 mL, 3.39 mmol, 3.0 equivalent) was slowly added dropwise at -78 °C. After 5 minutes, PivCl (0.28 mL, 2.26 mmol, 2.0 equivalent) was slowly added dropwise. The reaction mixture was kept at -78 °C for 10 minutes, then stirred at room temperature for 1 hour. After 1 hour, the reaction vessel was recooled to -78 °C. In a separate flame-dried flask, the reaction vessel was purged three times with argon. The substrate (400 mg, 2.26 mmol, 2.0 equivalent) was dissolved in tetrahydrofuran (6.5 mL), and the flask was cooled to -78 °C. After 10 minutes, slowly add dropwise at -78 ℃. n BuLi (1.48 mL, 1.6 M THF solution, 2.37 mmol, 2.1 equivalence). The reaction mixture was kept at -78 °C for 20 minutes. Add the following to the second reaction flask: nAfter holding the solution at -78 °C for 20 minutes, the solution in the flask was quickly aspirated using a long needle and syringe and rapidly transferred to the first reaction flask. The reaction was continued at -78 °C with stirring for 3 hours. After 3 hours, the temperature was increased in a programmed gradient: first to -60 °C and held for 10 minutes, then to -50 °C and held for 10 minutes, and so on, finally to 0 °C and held for 10 minutes. The reaction flask was then brought to room temperature and stirred for 12 hours. After 12 hours, the reaction progress was monitored by thin-layer chromatography. After the reaction was complete, a saturated ammonium chloride aqueous solution (20 mL) was added to quench the reaction. The organic phase was extracted with ethyl acetate (25 mL × 3). The combined organic phases were washed with brine (50 mL), dried over sodium sulfate, filtered, concentrated, and purified by rapid column chromatography (petroleum ether / ethyl acetate = 4 / 1) to give compound 14 (445 mg, yield 88%).

[0103] Data for compound 14: 1 H NMR (400 MHz, CDCl3) δ 7.34 (dd, J = 8.0, 6.5 Hz, 2H), 7.29 (d, J = 7.4Hz, 1H), 7.23 – 7.19 (m, 2H), 5.40 (t, J = 6.4 Hz, 1H), 4.67 (s, 3H), 4.29 (t, J = 8.5 Hz, 1H), 4.25 – 4.19 (m, 3H), 3.73 – 3.64 (m, 2H), 3.34 (dd, J = 13.4, 3.3 Hz, 1H), 2.81 (dd, J = 13.4, 9.5 Hz, 1H), 2.40 (t, J = 7.1 Hz, 2H), 1.69 (s, 3H), 0.90 (s, 9H), 0.07 (s, 6H). 13 C NMR(100 MHz, CDCl3) δ 170.42, 153.55, 135.09, 133.62, 129.53,129.15, 127.59, 126.57, 70.79, 70.70, 67.40, 60.32, 54.94, 39.46, 37.92,26.14, 18.55, 16.77, -4.94. Synthesis of Compound 15

[0104] The mixture was purged three times with argon in a flame-dried flask. Substrate 14 (650 mg, 1.45 mmol, 1.0 equivalent) was dissolved in dichloromethane (37 mL), and the reaction flask was cooled to -78 °C. After 10 minutes, Et3N (1.21 mL, 8.7 mmol, 6.0 equivalent) was slowly added dropwise at -78 °C. After 5 minutes, Et3N was slowly added dropwise. n Bu₂B·OTf (7.25 mL, 1 M dichloromethane solution, 7.25 mmol, 5.0 equivalence). The reaction mixture was kept at -78 °C for 30 min, then transferred to 0 °C and stirred for 2 h. After 2 h, the reaction flask was recooled to -78 °C. After cooling, CH₃CHO solution (2.9 mL, 5 M THF solution, 14.5 mmol, 10.0 equivalence) was slowly added dropwise. The reaction was stirred at -78 °C for 2 h, then heated to -20 °C and stirred at this temperature for 14 h. After 14 h, the reaction progress was monitored by thin-layer chromatography. After the reaction was complete, the reaction was quenched with saturated sodium bicarbonate aqueous solution (20 mL). The organic phase was extracted with dichloromethane (25 mL × 3). The combined organic phases were washed with brine (50 mL), dried over sodium sulfate, filtered, concentrated, and purified by rapid column chromatography (petroleum ether / ethyl acetate = 1 / 1) to give compound 15 (584 mg, yield 82%).

[0105] Data for compound 15: 1 H NMR (400 MHz, CDCl3) δ 7.33 (dd, J = 8.0, 6.5 Hz, 2H), 7.30 – 7.27 (m,1H), 7.24 – 7.20 (m, 2H), 5.43 – 5.38 (m, 1H), 4.98 (d, J = 2.7 Hz, 1H), 4.74 –4.66 (m, 1H), 4.19 (s, 4H), 4.09 – 4.02 (m, 1H), 3.81 (dt, J = 9.3, 6.7 Hz, 1H), 3.51 (dt, J = 9.2, 7.0 Hz, 1H), 3.36 (dd, J = 13.4, 3.3 Hz, 1H), 2.84 (dd, J=13.4, 9.5 Hz, 1H), 2.44 – 2.31 (m, 3H), 1.68 (s, 3H), 1.30 (d, J = 6.4 Hz, 3H), 0.89 (s, 9H), 0.06 (s, 6H). 13 C NMR(100 MHz, CDCl3) δ 171.03, 153.70, 135.13, 133.43, 129.54,129.13, 127.60, 126.80, 81.28, 69.50, 68.84, 67.13, 60.24, 55.79, 39.51,37.90, 26.12, 20.01, 18.53, 16.67, -4.98. Synthesis of Compound 16

[0106] The flame-dried flask was purged three times with argon. Substrate 15 (715 mg, 1.46 mmol, 1.0 equivalent) was dissolved in DMF (15 mL), and the reaction flask was cooled to 0 °C. After 10 minutes, imidazole (497 mg, 7.3 mmol, 5.0 equivalent) was added in a single batch, and stirring was continued at 0 °C for 50 minutes. After 50 minutes, TBSCl (660 mg, 4.38 mmol, 3.0 equivalent) was added to the reaction flask. The mixture was then heated to room temperature and stirred at room temperature for 14 hours. After 14 hours, the reaction progress was monitored by thin-layer chromatography. After the reaction was complete, water (20 mL) was added to quench the reaction. The organic phase was extracted with dichloromethane (25 mL × 3). The combined organic layers were washed with brine (50 mL), dried over anhydrous sodium sulfate, filtered, concentrated, and purified by rapid column chromatography (petroleum ether / ethyl acetate = 10 / 1) to give the silane-protected product (787 mg, 89%).

[0107] The flame-dried flask was purged three times with argon. The above-mentioned silicon-based protected product (495 mg, 0.82 mmol, 1.0 equivalent) was placed in THF (8 mL), and the reaction flask was cooled to 0 °C. After 10 minutes, NaBH4 (155 mg, 4.1 mmol, 5.0 equivalent) was dissolved in water (2.7 mL), and this sodium borohydride aqueous solution was slowly added dropwise to the reaction flask at 0 °C, while stirring was continued at 0 °C for 10 minutes. After 10 minutes, the reaction flask was heated to room temperature and stirred vigorously at room temperature for 14 hours. After 14 hours, the reaction progress was monitored by thin-layer chromatography. After the reaction was complete, water (20 mL) was added to quench the reaction. The organic phase was extracted with ethyl acetate (25 mL × 3). The combined organic layers were washed with brine (30 mL), dried over anhydrous sodium sulfate, filtered, concentrated, and purified by rapid column chromatography (petroleum ether / ethyl acetate = 6 / 1) to give the hydroxyl product (252 mg, 71%).

[0108] The flame-dried flask was purged three times with argon. The above hydroxyl product (566 mg, 1.31 mmol, 1.0 equivalent) was placed in dichloromethane (130 mL), and the reaction flask was cooled to 0 °C. NaHCO3 (557 mg, 6.55 mmol, 5.0 equivalent) was added to the reaction flask. After 10 minutes, DMP (1.67 g, 3.93 mmol, 3.0 equivalent) was added to the reaction flask. After 5 minutes, the reaction flask was heated to room temperature and stirred at room temperature for 3 hours. After 3 hours, the reaction progress was monitored by thin-layer chromatography. After the reaction was complete, the reaction was quenched with saturated sodium thiosulfate aqueous solution (45 mL), and stirring was continued at room temperature for 2 hours. After 2 hours, the organic phase was extracted with dichloromethane (40 mL × 3). The combined organic layers were washed with brine (50 mL), dried over anhydrous sodium sulfate, filtered, concentrated, and purified by rapid column chromatography (petroleum ether / ethyl acetate = 7 / 1) to give compound 16 (338 mg, 60%). Compound 16 was unstable and proceeded directly to the next reaction step.

[0109] Synthesis of Compound 17

[0110] The flame-dried flask was purged three times with argon. Diethyl allylphosphonate (0.27 mL, 1.58 mmol, 2.0 equivalent) was placed in THF (0.2 mL), and the reaction flask was cooled to -78 °C. After 10 minutes, the flask was slowly filled dropwise with argon. nBuLi (0.74 mL, 1.6 M THF solution, 1.19 mmol, 1.5 equivalence). The reaction mixture was kept at -78 °C for 20 min, during which time it turned into a milky white solution. After 20 min, substrate 16 (338 mg, 0.79 mmol, 1.0 equivalence) and HMPA (0.22 mL, 1.26 mmol, 1.6 equivalence) obtained in the previous step were slowly transferred to the reaction flask via THF (2 mL), and stirring was continued at -78 °C for 2 h, at which point the solution turned yellow. After 2 h, the reaction flask was warmed to room temperature and stirred at room temperature for 14 h. After 14 h, the reaction progress was monitored by thin-layer chromatography. After the reaction was complete, the reaction was quenched by adding saturated ammonium chloride aqueous solution (5 mL). The organic phase was extracted with ethyl acetate (15 mL × 3). The combined organic layers were washed with brine (30 mL), dried over anhydrous sodium sulfate, filtered, concentrated, and purified by rapid column chromatography (petroleum ether / ethyl acetate = 6 / 1) to give compound 17 (179 mg, 50%).

[0111] Data for compound 17: 1 H NMR (400 MHz, CDCl3) δ 6.40 (s, 1H), 6.24 – 6.17 (m, 1H), 5.57 (dd, J = 15.3, 7.2 Hz, 1H), 5.34 (s, 1H), 5.19 (dd, J = 16.7, 1.7 Hz, 1H), 5.07 (dd, J =10.0, 1.7 Hz, 1H), 4.18 (d, J = 6.3 Hz, 2H), 3.84 – 3.76 (m, 1H), 3.59 (s, 2H), 3.43 – 3.36 (m, 1H), 2.27 (t, J = 7.1 Hz, 2H), 1.63 (d, J = 1.2 Hz, 3H), 1.04 (d, J = 6.3 Hz, 3H), 0.90 (s, 9H), 0.88 (s, 9H), 0.06 (t, J = 1.8 Hz, 12H). 13C NMR(100 MHz, CDCl3) δ 136.74, 134.21, 133.64, 131.70, 126.23,117.08, 84.86, 70.62, 68.13, 60.39, 39.93, 26.17, 26.01, 19.46, 18.58, 18.34,16.83, 1.17, -4.43, -4.55, -4.91. Synthesis of Compound 9

[0112] The flame-dried flask was purged three times with argon. Substrate 17 (139 mg, 0.31 mmol, 1.0 equivalent) was placed in dichloromethane (24.8 mL) and methanol (6.2 mL), and the reaction flask was cooled to 0 °C. After 10 minutes, p-toluenesulfonic acid (9 mg, 0.05 mmol, 0.15 equivalent) was added to the reaction flask. The reaction mixture was stirred at 0 °C for 2 hours. After 2 hours, the reaction progress was monitored by thin-layer chromatography. After the reaction was complete, the reaction was quenched with saturated sodium bicarbonate aqueous solution (20 mL). The organic phase was first concentrated to remove methanol, and then extracted with dichloromethane (25 mL × 3). The combined organic layers were washed with brine (30 mL), dried over anhydrous sodium sulfate, filtered, concentrated, and purified by rapid column chromatography (petroleum ether / ethyl acetate = 4 / 1) to give the desilication product (71 mg, 67%).

[0113] The flame-dried flask was purged three times with argon. The desilication product (39 mg, 0.11 mmol, 1.0 equivalent) was placed in dichloromethane (12 mL), and the reaction flask was cooled to 0 °C. Then, NaHCO3 (56 mg, 0.66 mmol, 6.0 equivalent) was added to the reaction flask. After 10 minutes, DMP (187 mg, 0.44 mmol, 4.0 equivalent) was added to the reaction flask. The reaction flask was then heated to room temperature and stirred at room temperature for 1 hour. After 1 hour, the reaction progress was monitored by thin-layer chromatography. After the reaction was complete, the reaction was quenched with saturated sodium thiosulfate aqueous solution (10 mL), and then extracted with dichloromethane (13 mL × 3). The combined organic layers were washed with brine (20 mL), dried over anhydrous sodium sulfate, filtered, and concentrated. The resulting residue was used directly in the next step without purification.

[0114] The flame-dried flask was purged three times with argon. The substrate obtained in the previous step was placed in tert-butanol (6 mL). Then, with stirring, 3-methyl-1-butene (0.31 mL, 2.75 mmol, 25.0 equivalents) was added to the reaction flask. In a separate 20 mL glass vial, NaClO2 (124 mg, 1.1 mmol, 10.0 equivalents) and NaH2PO4 (92 mg, 0.77 mmol, 7.0 equivalents) were added, followed by 2 mL of water. The mixture was dissolved by sonication, and the resulting aqueous solution was added to the reaction flask. The reaction mixture was stirred at room temperature for 4 hours. After 4 hours, the reaction progress was monitored by thin-layer chromatography. After the reaction was complete, the reaction was quenched with water (6 mL) and then extracted with ethyl acetate (10 mL × 3). The combined organic layers were washed with brine (10 mL), dried over anhydrous sodium sulfate, filtered, concentrated, and purified by rapid column chromatography (petroleum ether / ethyl acetate = 3 / 1) to give compound 9 (31 mg, 80%).

[0115] Data for compound 9: 1 H NMR (400 MHz, CDCl3) δ 6.40 (s, 1H), 6.26 – 6.14 (m, 1H), 5.72 (d, J =1.9 Hz, 1H), 5.54 (dd, J = 15.3, 7.4 Hz, 1H), 5.21 (d, J = 16.7 Hz, 1H), 5.09(dd, J = 10.1, 1.6 Hz, 1H), 3.78 (p, J = 6.3 Hz, 1H), 3.68 – 3.51 (m, 2H), 3.46(dt, J = 9.4, 6.4 Hz, 1H), 2.49 – 2.36 (m, 2H), 2.18 (s, 3H), 1.04 (d, J = 6.3Hz, 3H), 0.88 (s, 9H), 0.06 (s, 6H). 13C NMR(100 MHz, CDCl3) δ 172.04, 160.26, 136.49, 134.05, 131.21,117.56, 116.68, 85.22, 70.60, 66.80, 41.47, 26.00, 25.98, 19.60, 19.40,18.32, -4.46, -4.58. II. Preparation of compound roridin E The synthetic route for compound roridin E is shown below:

[0116] Synthesis of Compound 19

[0117] The flame-dried flask was purged three times with argon. Substrate 7 (202 mg, 0.59 mmol, 1.0 equivalent) was placed in dichloromethane (10 mL). Then, with stirring, Et3N (0.57 mL, 4.13 mmol, 7.0 equivalent) and DMAP (37 mg, 0.30 mmol, 0.5 equivalent) were added sequentially to the reaction flask. After 10 minutes, acrylic anhydride (0.34 mL, 2.95 mmol, 5.0 equivalent) was added to the above reaction flask. The reaction mixture was stirred at room temperature for 2 hours. After 2 hours, the reaction progress was monitored by thin-layer chromatography. After the reaction was complete, the reaction was quenched with water (10 mL) and then extracted with dichloromethane (30 mL × 3). The combined organic layers were washed with brine (50 mL), dried over anhydrous sodium sulfate, filtered, and concentrated to obtain the crude esterified product.

[0118] Preparation of the zinc-silver complex: Acetic acid (23 mL) was added to a 75 mL sealed tube, followed by zinc powder (4.16 g). The sealed tube was heated to 118 °C and refluxed. AgOAc (23 mg) was then added, and the mixture was refluxed at 118 °C for 1 minute. After 1 minute, the acetic acid was removed by suction filtration, and the residue was washed successively with acetic acid (10 mL) and diethyl ether (5 × 10 mL) to obtain the freshly prepared zinc-silver complex.

[0119] The flame-dried flask was purged three times with argon. The esterified product was placed in THF (59 mL), EtOH (9.8 mL), and diethyl ether (18.6 mL). Then, with stirring, the freshly prepared zinc-silver complex (1.92 g) was added to the reaction flask. The reaction mixture was refluxed at 55 °C for 12 hours. After 12 hours, the reaction progress was monitored by thin-layer chromatography. After the reaction was complete, the mixture was filtered directly through diatomaceous earth and 200-300 mesh silica gel and washed with ethyl acetate (30 mL). The combined organic layers were concentrated and purified by rapid column chromatography (petroleum ether / ethyl acetate = 3 / 1) to give compound 19 (128 mg, 68%).

[0120] Data for compound 19: 1 H NMR (500 MHz, CDCl3) δ 6.45 (dd, J = 17.3, 1.4 Hz, 1H), 6.16 (dd, J =17.3, 10.4 Hz, 1H), 6.11 (dd, J = 8.1, 3.8 Hz, 1H), 5.87 (dd, J = 10.5, 1.4 Hz,1H), 5.50 – 5.46 (m, 1H), 3.91 (d, J = 5.7 Hz, 1H), 3.85 – 3.80 (m, 2H), 3.65(d, J = 12.4 Hz, 1H), 3.13 (d, J = 4.0 Hz, 1H), 2.81 (d, J = 4.0 Hz, 1H), 2.57 (s,1H), 2.49 (dd, J = 15.3, 8.1 Hz, 1H), 2.13 – 2.07 (m, 1H), 2.04 – 1.93 (m, 3H), 1.71 (s, 3H), 1.58 – 1.52 (m, 1H), 0.82 (s, 3H). 13 C NMR(125 MHz, CDCl3) δ 167.19, 140.64, 131.82, 128.26, 118.89,79.12, 75.89, 66.94, 65.69, 62.97, 49.05, 48.26, 44.38, 36.06, 28.17, 23.39,21.35, 6.59. Synthesis of Compound 20

[0121] The flame-dried flask was purged three times with argon. Acid substrate 9 (49 mg, 0.14 mmol, 1.0 equivalent) and THF (2.8 mL) were transferred to the reaction flask. The flask was then placed in an ice bath at 0 °C. After 10 minutes, Et3N (29 μL, 0.21 mmol, 1.5 equivalent) and 2,4,6-trichlorobenzoyl chloride (33 μL, 0.21 mmol, 1.5 equivalent) were slowly added sequentially to the flask. The reaction mixture was then stirred at room temperature for 3 hours. After 3 hours, the mixture was concentrated to remove THF and then dried under vacuum using an oil pump. The flask was purged three times with argon. Ultra-dry toluene (0.8 mL) was added to dissolve the residue, and the flask was placed in an ice bath at -10 °C. A solution of alcohol substrate 19 (45 mg, 0.14 mmol, 1.0 equivalent) and DMAP (51 mg, 0.42 mmol, 3.0 equivalent) in toluene (2 mL) was slowly added dropwise to the reaction mixture. The reaction was continued with stirring at -10 °C for 16 h. The reaction progress was monitored by thin-layer chromatography (TLC). After the reaction was complete, the reaction was quenched with NaHCO3 solution (2 mL). The aqueous layer was extracted with ethyl acetate (10 mL × 3). The combined organic layers were washed with saturated sodium chloride solution (10 mL), dried over anhydrous sodium sulfate, filtered, concentrated, and purified by rapid column chromatography (petroleum ether / ethyl acetate = 3 / 1) to give compound 20 (55 mg, 60%).

[0122] Data for compound 20: 1 H NMR (500 MHz, CDCl3) δ 6.44 – 6.38 (m, 1H), 6.38 – 6.29 (m, 1H), 6.10 (s, 2H), 5.82 (dd, J = 10.3, 1.0 Hz, 1H), 5.74 (d, J = 17.9 Hz, 1H), 5.69(d, J = 7.6 Hz, 1H), 5.60 – 5.50 (m, 1H), 5.43 (d, J = 5.5 Hz, 1H), 5.22 – 5.14(m, 1H), 5.07 (dd, J = 12.4, 10.2 Hz, 1H), 4.19 (dd, J = 16.1, 12.3 Hz, 1H), 4.03(dd,J = 12.4, 4.4 Hz, 1H), 3.83 (d, J = 5.2 Hz, 1H), 3.82 – 3.75 (m, 1H), 3.75 –3.71 (m, 1H), 3.64 – 3.53 (m, 2H), 3.51 – 3.42 (m, 1H), 3.14 (d, J = 5.2 Hz, 1H), 2.90 (d, J = 15.7 Hz, 1H), 2.84 (d, J = 4.3 Hz, 1H), 2.61 – 2.54 (m, 1H), 2.36 (s, 1H), 2.17 (s, 1H), 2.05 – 1.92 (m, 5H), 1.79 (s, 1H), 1.70 (s, 3H), 1.60 (d, J = 4.9 Hz, 1H), 1.02 (s, 3H), 0.87 (s, 9H), 0.83 (s, 3H), 0.05 (s, 6H). 13 C NMR(125 MHz, CDCl3) δ 166.18, 165.85, 165.67, 159.46, 158.25,141.23, 141.16, 136.71, 136.54, 133.98, 133.69, 131.48, 131.31, 131.18,128.60, 128.58, 118.42, 118.39, 117.46, 117.10, 116.78, 116.70, 85.11, 84.52,79.21, 75.75, 75.70, 70.58, 70.45, 67.85, 67.14, 67.10, 66.84, 65.54, 62.73, 49.13, 49.10, 48.04, 43.48, 43.44, 41.29, 37.01, 36.98, 34.06, 28.16, 28.14, 26.28, 26.03, 26.02, 25.99, 23.38, 21.31, 21.26, 19.55, 19.33, 19.08, 18.32, 18.30, 7.09, 7.06, -4.44, -4.46, -4.56. Synthesis of compound roridin E

[0123] The flame-dried flask was purged three times with argon. In a glove box, substrate 20 (19.7 mg, 0.03 mmol, 1.0 equivalent), CH2Cl2 (15 mL), and Hoveyda–Grubbs second-generation catalyst (13 mg, 0.02 mmol, 0.5 equivalent) were transferred in a single batch to a sealed tube. The mixture was bubbled with an argon balloon for 30 minutes. The sealed tube was then placed in a 50 °C oil bath and stirred at this temperature for 3 days. After 3 days, the reaction progress was monitored by thin-layer chromatography (TLC). After the reaction was complete, the sealed tube was cooled to 0 °C, and 2 drops of Et3N were added to quench the reaction. The mixture was then stirred at room temperature for 3 hours. After 3 hours, the mixture was directly concentrated without further purification and used directly for the next step.

[0124] The substrate obtained in the previous step was dissolved in MeCN (2.9 mL). Et3N (802 μL) and Et3N·3HF (961 μL) were added sequentially to the reaction flask. The mixture was stirred at room temperature for 24 hours. After 24 hours, the reaction progress was monitored by TLC. After the reaction was complete, the reaction mixture was slowly added to a pre-prepared saturated NaHCO3 solution. After quenching, the aqueous layer was extracted with ethyl acetate (20 mL × 3). The combined organic layers were washed with saturated sodium chloride solution (10 mL), dried over anhydrous sodium sulfate, filtered, concentrated, and purified by rapid column chromatography (petroleum ether / ethyl acetate = 1 / 1) to give roridin E (6.9 mg, 45%).

[0125] Data for roridin E: 1 H NMR (600 MHz, CDCl3) δ 7.52 (dd, J = 15.8, 11.3 Hz, 1H), 6.57 (t, J =11.3 Hz, 1H), 6.21 (dd, J = 8.2, 3.9 Hz, 1H), 5.96 (d, J = 1.7 Hz, 1H), 5.90 (dd, J = 15.7, 3.3 Hz, 1H), 5.75 (d, J = 11.2 Hz, 1H), 5.48 (m, 1H), 4.31 (d, J = 12.5Hz, 1H), 3.93 (d, J = 12.6 Hz, 1H), 3.90 (d, J= 5.7 Hz, 1H), 3.85 (d, J = 5.1 Hz,1H), 3.69 (m, 1H), 3.63 (m, 2H), 3.57 (m, 1H), 3.14 (d, J = 4.0 Hz, 1H), 2.82(d, J = 4.1 Hz, 1H), 2.53 (m, 1H), 2.50 (m, 2H), 2.26 (d, J = 1.4 Hz, 3H), 2.05(m, 1H), 2.02 (m, 2H), 2.01 (m, 1H), 1.71 (s, 3H), 1.66 (m, 1H), 1.20 (d, J =6.2 Hz, 3H), 0.79 (s, 3H). 13 C NMR(150 MHz, CDCl3) δ 166.46, 165.81, 159.24, 143.64, 140.22,137.99, 126.51, 118.81, 117.79, 117.13, 83.93, 79.20, 74.16, 70.68, 69.86,67.19, 65.59, 63.71, 48.37, 48.14, 42.67, 41.21, 35.79, 27.65, 23.25, 21.56,20.33, 18.25, 6.67. Example 3 Preparation of compound Verrucarin J I. Preparation of branched compound 10 The synthetic route for compound 10 is shown below:

[0126] Synthesis of Compound 18

[0127] The flame-dried flask was purged three times with argon. Compound 13 (200 mg, 0.87 mmol, 1.0 equivalent) was transferred to the reaction flask, and 30 mL of dichloromethane was added. Subsequently, DCC (359 mg, 1.74 mmol, 2.0 equivalent), DMAP (21 mg, 0.17 mmol, 0.2 equivalent), and the conjugate acid (94 mg, 0.96 mmol, 1.1 equivalent) were added sequentially to the flask. The reaction mixture was then stirred at room temperature for 14 hours. After 14 hours, the reaction progress was monitored by thin-layer chromatography (TLC). After the reaction was complete, water (5 mL) was added to quench the reaction, and the mixture was extracted with dichloromethane (10 mL × 4). The combined organic phases were washed with saturated sodium chloride solution (10 mL), dried over anhydrous sodium sulfate, filtered, and concentrated. The residue was purified by rapid column chromatography (petroleum ether / ethyl acetate = 7 / 1) to give compound 18 (237 mg, 88%).

[0128] Data for compound 18: 1 H NMR (400 MHz, CDCl3) δ 7.25 – 7.18 (m, 1H), 6.42 (dddd, J = 16.9,10.9, 9.9, 0.7 Hz, 1H), 5.87 (d, J = 16.4 Hz, 1H), 5.58 (d, J = 17.0 Hz, 1H),5.50 – 5.44 (m, 1H), 5.36 (d, J = 14.3 Hz, 1H), 4.22 (t, J = 6.9 Hz, 2H), 4.19 –4.15 (m, 2H), 2.34 (t, J = 6.9 Hz, 2H), 1.65 (s, 3H), 0.87 (s, 9H), 0.04 (s, 6H). 13 C NMR(100 MHz, CDCl3) δ 166.94, 144.89, 134.88, 132.82, 127.25,125.72, 122.24, 62.86, 60.30, 38.60, 26.12, 18.54, 16.59, -4.94. Synthesis of Compound 10

[0129] The flame-dried flask was purged three times with argon. Substrate 18 (200 mg, 0.64 mmol, 1.0 equivalent) was placed in tetrahydrofuran (64 mL). TBAF (2.56 mL, 1 M THF solution, 2.56 mmol, 4.0 equivalent) was then added to the reaction flask, and the mixture was stirred at room temperature for 2 hours. After 2 hours, the reaction progress was monitored by TLC. After the reaction was complete, the reaction was quenched with saturated ammonium chloride solution (30 mL), and the organic layer was extracted with ethyl acetate (40 mL × 3). The combined organic layers were washed with brine (50 mL), dried over anhydrous sodium sulfate, filtered, concentrated, and purified by rapid column chromatography (petroleum ether / ethyl acetate = 2 / 1) to give the desilication product (95 mg, 76%).

[0130] The flame-dried flask was purged three times with argon. The desilication product (60 mg, 0.31 mmol, 1.0 equivalent) was placed in dichloromethane (31 mL), and the reaction flask was cooled to 0 °C. Then, NaHCO3 (156 mg, 1.86 mmol, 6.0 equivalent) was added to the reaction flask. After 10 minutes, DMP (526 mg, 1.24 mmol, 4.0 equivalent) was added to the reaction flask. The reaction flask was then heated to room temperature and stirred at room temperature for 2 hours. After 2 hours, the reaction progress was monitored by thin-layer chromatography. After the reaction was complete, the reaction was quenched with saturated sodium thiosulfate aqueous solution (15 mL), and then extracted with dichloromethane (25 mL × 3). The combined organic layers were washed with brine (30 mL), dried over anhydrous sodium sulfate, filtered, and concentrated. The resulting residue was used directly in the next step without purification.

[0131] The flame-dried flask was purged three times with argon. The substrate obtained in the previous step was placed in tert-butanol (8 mL). Then, with stirring, 3-methyl-1-butene (0.87 mL, 7.75 mmol, 25.0 equivalents) was added to the reaction flask. In a separate 20 mL glass vial, NaClO2 (350 mg, 3.1 mmol, 10.0 equivalents) and NaH2PO4 (260 mg, 2.17 mmol, 7.0 equivalents) were added, followed by 4 mL of water. The mixture was dissolved by sonication, and the resulting aqueous solution was added to the reaction flask. The reaction mixture was stirred at room temperature for 4 hours. After 4 hours, the reaction progress was monitored by thin-layer chromatography. After the reaction was complete, the reaction was quenched with water (10 mL) and then extracted with ethyl acetate (25 mL × 3). The combined organic layers were washed with brine (10 mL), dried over anhydrous sodium sulfate, filtered, concentrated, and purified by rapid column chromatography (petroleum ether / ethyl acetate = 3 / 1) to give compound 10 (46 mg, 71%).

[0132] Data for compound 10: 1 H NMR (400 MHz, CDCl3) δ 7.30 – 7.20 (m, 1H), 6.44 (dt, J = 16.9, 10.5Hz, 1H), 5.89 (d, J = 15.4 Hz, 1H), 5.75 (q, J = 1.3 Hz, 1H), 5.62 (dd, J = 16.8,1.3 Hz, 1H), 5.53 – 5.47 (m, 1H), 4.31 (t, J = 6.5 Hz, 2H), 2.56 – 2.49 (m,2H), 2.21 (s, 3H). 13 C NMR (100 MHz, CDCl3) δ 171.69, 166.76, 158.33, 145.39, 134.75, 126.13, 121.72, 117.42, 61.71, 40.02, 19.14. II. Preparation of compound verrucarin J The synthetic route for compound verrucarin J is shown below:

[0133] Synthesis of Compound 21

[0134] The flame-dried flask was purged three times with argon. Acid substrate 10 (15 mg, 0.07 mmol, 1.0 equivalent) and THF (1.43 mL) were transferred to the reaction flask. The flask was then placed in an ice bath at 0 °C. After 10 minutes, Et3N (15 μL, 0.11 mmol, 1.5 equivalent) and 2,4,6-trichlorobenzoyl chloride (17 μL, 0.11 mmol, 1.5 equivalent) were slowly added sequentially to the flask. The reaction mixture was then stirred at room temperature for 3 hours. After 3 hours, the mixture was concentrated to remove THF and then dried under vacuum using an oil pump. The flask was purged three times with argon. Ultra-dry toluene (0.51 mL) was added to dissolve the residue, and the flask was placed in an ice bath at -10 °C. A solution of alcohol substrate 19 (22 mg, 0.07 mmol, 1.0 equivalent) and DMAP (26 mg, 0.21 mmol, 3.0 equivalent) in toluene (1.2 mL) was slowly added dropwise to the reaction mixture. The reaction was continued with stirring at -10 °C for 16 hours. The reaction progress was monitored by thin-layer chromatography (TLC). After the reaction was complete, the reaction was quenched with NaHCO3 solution (2 mL). The aqueous layer was extracted with ethyl acetate (12 mL × 3). The combined organic layers were washed with saturated sodium chloride solution (10 mL), dried over anhydrous sodium sulfate, filtered, concentrated, and purified by rapid column chromatography (petroleum ether / ethyl acetate = 3 / 1) to give compound 21 (16 mg, 45%).

[0135] Data for compound 21: 1 H NMR (400 MHz, CDCl3) δ 6.49 – 6.37 (m, 2H), 6.12 (dd, J = 16.6, 11.2Hz, 1H), 5.88 (d, J = 15.5 Hz, 1H), 5.84 – 5.80 (m, 1H), 5.79 – 5.69 (m, 2H), 5.64 – 5.56 (m, 1H), 5.49 (dd, J = 10.1, 4.2 Hz, 1H), 5.42 (d, J = 5.4 Hz, 1H), 4.29 (t, J = 6.7 Hz, 2H), 4.21 (dd, J = 12.4, 5.6 Hz, 1H), 4.03 (dd, J = 12.4, 2.1Hz, 1H), 3.83 (d, J = 5.1 Hz, 1H), 3.73 (t,J = 4.3 Hz, 1H), 3.13 (d, J = 4.3 Hz, 1H), 2.83 (d, J = 4.1 Hz, 1H), 2.56 (dd, J = 15.6, 7.8 Hz, 1H), 2.50 (t, J = 6.7Hz, 1H), 2.20 (s, 2H), 2.05 – 1.99 (m, 2H), 1.99 (s, 3H), 1.70 (s, 3H), 1.32– 1.21 (m, 3H), 0.81 (d, J = 3.7 Hz, 3H). Synthesis of compound verrucarin J

[0136] The flame-dried flask was purged three times with argon. In a glove box, substrate 21 (10.1 mg, 0.02 mmol, 1.0 equivalent), CH2Cl2 (10 mL), and Hoveyda–Grubbs second-generation catalyst (6 mg, 0.01 mmol, 0.5 equivalent) were transferred in a single batch to a sealed tube. The mixture was bubbled with an argon balloon for 30 minutes. The sealed tube was then placed in an oil bath at 50 °C and stirred at this temperature for 3 days. After 3 days, the reaction progress was monitored by thin-layer chromatography (TLC). After the reaction was complete, the sealed tube was cooled to 0 °C, and 2 drops of Et3N were added to quench the reaction. The mixture was then stirred at room temperature for 3 hours. After 3 hours, the mixture was concentrated and purified by rapid column chromatography (petroleum ether / ethyl acetate = 3 / 1) to give an inseparable mixture of verrucarin J and its isomers, totaling 5.9 mg (61%).

[0137] Data for compound verrucarin J: 1 H NMR (600 MHz, CDCl3) δ 8.06 (dd, J = 15.7, 11.6 Hz, 1H), 6.62 (t, J =11.1 Hz, 1H), 6.10 (d, J = 11.1 Hz, 1H), 6.02 – 5.99 (m, 1H), 5.99 (dd, J = 8.0,4.2 Hz, 1H), 5.83 (m, 1H), 5.46 (d, J= 5.6 Hz, 1H), 4.46 (d, J = 16.1 Hz, 1H), 4.43 (d, J = 13.1 Hz, 1H), 4.15 (m, 1H), 3.97 (d, J = 12.6 Hz, 1H), 3.85 (d, J =5.1 Hz, 1H), 3.75 (d, J = 5.5 Hz, 1H), 3.14 (m, 1H), 2.83 (d, J = 4.0 Hz, 1H),2.53 (m, 1H), 2.50 (t, 1H), 2.28 (d, J = 1.3 Hz, 3H), 2.20 - 1.93 (m, 6H), 1.72 (s, 3H), 0.83 (s, 3H). 13 C NMR(150 MHz, CDCl3) δ 165.86, 165.58, 165.30, 156.36, 140.22,139.23, 138.89, 127.15, 125.28, 118.40, 117.90, 78.81, 75.10, 67.05, 65.24,63.08, 60.20, 48.61, 47.82, 42.81, 39.97, 34.89, 27.42, 23.03, 20.52, 16.97,6.74. The above description is merely a preferred embodiment of the present invention and is not intended to limit the invention. Various modifications and variations can be made to the present invention by those skilled in the art. Any modifications, equivalent substitutions, improvements, etc., made within the spirit and principles of the present invention should be included within the scope of protection of the present invention.

Claims

1. A method for synthesizing trichothecene toxins, characterized in that, This includes the steps for obtaining compound 7 via the following reaction route; ; And the steps for obtaining verrucarol from compound 7 via the following reaction route; 。 2. The preparation method according to claim 1, characterized in that, in Compound 7 reacted with zinc powder and NH4Cl at room temperature for 18-20 hours under anhydrous, oxygen-free, and room temperature conditions. Specifically, the molar ratio of compound 7 to zinc powder and NH4Cl was 1:15-25:15-25.

3. A method for synthesizing macrocyclic trichothecene toxins, characterized in that, This includes the steps for obtaining compound 7 via the following reaction route; ; And, the steps of obtaining roridin E or Verrucarin J from compound 7 via the following reaction route; 。 4. The synthesis method as described in claim 1 or 3, characterized in that, In step 1) of the process for preparing compound 1', the molar ratio of compound 1 to SeO2 and TBHP is 1:0.25~0.35:0.7~0.9; Alternatively, in step 1) of the process for preparing compound 1', mixing and reaction are carried out at 0~5°C; Alternatively, in step 2) of the process for preparing compound 1', mixing and reaction are carried out under anhydrous and oxygen-free conditions; Alternatively, in step 2) of the process for preparing compound 1', the molar amount of Me2N=CH2I added is 2.5 to 3.5 times the molar amount of compound 1; Alternatively, in step 2) of the process for preparing compound 1', Et3N is added; preferably, the molar amount of Et3N added is 2.5 to 3.5 times the molar amount of compound 1; Alternatively, in step 2) of the process for preparing compound 1', the reaction temperature is room temperature and the reaction time is 16-24 hours; Alternatively, in step 1) of the process of preparing compound 2 from compound 1', the molar amount of NaClO2 added is 9 to 11 times the molar amount of compound 1'; Alternatively, in step 1) of the process of preparing compound 2 from compound 1', NaH2PO4 is added; preferably, the molar amount of NaH2PO4 added is 6 to 8 times the molar amount of compound 1'; Alternatively, in step 1) of the process of preparing compound 2 from compound 1', 3-methyl-1-butene is added; preferably, the molar amount of 3-methyl-1-butene added is 20 to 30 times the molar amount of compound 1'; Alternatively, in step 1) of the process for preparing compound 2 from compound 1, the reaction is carried out at room temperature for 4 to 5 hours; Alternatively, in step 2) of the process of preparing compound 2 from compound 1', the solvent used is a mixed solution of dichloromethane and tetrahydrofuran; preferably, the volume ratio of dichloromethane to tetrahydrofuran is 1:0.9~1.1; Alternatively, in step 2) of the process for preparing compound 2 from compound 1, mixing and reaction are carried out under anhydrous and oxygen-free conditions; Alternatively, in step 2) of the process of preparing compound 2 from compound 1', the molar amount of MNBA added is 1.8 to 2.2 times the molar amount of compound 1'; Alternatively, in step 2) of the process of preparing compound 2 from compound 1', DMAP is added; preferably, the molar amount of DMAP added is 1.8 to 2.2 times the molar amount of compound 1'. Alternatively, in step 2) of the process of preparing compound 2 from compound 1, the reaction is carried out at room temperature for 14-16 hours; Alternatively, the molar ratio of compound 2 to compound 3 is 1:2.5~3.5; Alternatively, BHT may be added during the reaction of compound 2 and compound 3 to prepare compound 4; preferably, the molar ratio of compound 2 to BHT is 1:0.1~0.15; Alternatively, in the process of reacting compound 2 with compound 3 to prepare compound 4, the reaction temperature is 175~185 ℃ and the reaction time is 36~38 hours; Alternatively, the process for preparing compound 5 from compound 4 is as follows: under anhydrous and oxygen-free conditions, compound 4 is first reacted with compound 5 at 0~5℃. i The reaction of Bu2AlH lasts for 1.4–1.6 hours, followed by reaction of the product with TBAF at room temperature for 12.5–13.5 hours; preferably, compound 4 reacts with… i The molar ratio of Bu2AlH is 1:2.0~3.0; preferably, the molar ratio of the product after reaction to TBAF is 1:9~11; Alternatively, under anhydrous and oxygen-free conditions, compound 5 is reacted with (+)-CSA at room temperature for 8-10 hours to obtain compound 6; Alternatively, the molar ratio of compound 5 to (+)-CSA is 1:0.09~0.11; Alternatively, in step 1) of the process of preparing compound 7 from compound 6, compound 6 is reacted with KBr and Oxone for 6-8 hours under anhydrous, oxygen-free and room temperature conditions; preferably, the molar ratio of compound 6, KBr and Oxone is 1:3.5-4.5:3.5-4.

5. Alternatively, in step 2) of the process for preparing compound 7 from compound 6, under anhydrous and oxygen-free conditions and at 0-5°C, the product from the reaction in step 1) is reacted with ZnBr2. n PrSH is mixed, then heated to room temperature and reacted for 2-3 hours; preferably, the product of the previous reaction is reacted with ZnBr2, n The molar ratio of PrSH is 1:2.7~3.3:5.5~6.5; Alternatively, in step 3) of the process of preparing compound 7 from compound 6, the product of step 2) is mixed with VO(acac)2 under anhydrous and oxygen-free conditions and at 0~5°C, and then TBHP is added, and the mixture is heated to room temperature for 48~50 hours; preferably, the molar ratio of the product of step 2) to VO(acac)2 and TBHP is 1:0.13~0.17:2.5~3.

5.

5. The preparation method according to claim 3, characterized in that, Compound 7 is first esterified with acrylic anhydride, and then reacted with a zinc-silver complex under anhydrous and oxygen-free conditions under reflux for 12-14 hours to obtain compound 19; preferably, the reflux temperature is 53-57°C and the reflux time is 12-14 hours. Alternatively, under anhydrous and oxygen-free conditions, compound 9 is mixed with 2,4,6-trichlorobenzoyl chloride and Et3N at 0~5°C, then heated to room temperature and reacted for 3~4 hours; then cooled to -15~-5°C, compound 19 and DMAP are added, and the reaction is maintained at this temperature for 16~18 hours; preferably, the molar ratio of compound 9, 2,4,6-trichlorobenzoyl chloride, Et3N, compound 19 and DMAP is 1:1.3~1.7:1.3~1.7:0.9~1.1:2.5~3.5; Alternatively, under anhydrous and oxygen-free conditions, compound 20 is heated to 50-55°C and reacted with Hoveyda-Grubbs II for 3-4 days; then the product is reacted with Et3N and Et3N·3HF at room temperature for 24-26 hours; preferably, the molar ratio of compound 20, Hoveyda-Grubbs II, Et3N, and Et3N·3HF is 1:0.3-0.7:185-195:190-200. Alternatively, under anhydrous and oxygen-free conditions, compound 10 is mixed with 2,4,6-trichlorobenzoyl chloride and Et3N at 0~5°C, then heated to room temperature and reacted for 3~4 hours; then cooled to -15~-5°C, compound 19 and DMAP are added, and the reaction is maintained at this temperature for 16~18 hours; preferably, the molar ratio of compound 9, 2,4,6-trichlorobenzoyl chloride, Et3N, compound 19 and DMAP is 1:1.3~1.7:1.3~1.7:0.9~1.1:2.5~3.5; Alternatively, under anhydrous and oxygen-free conditions, compound 21 and Hoveyda-Grubbs II are heated to 50-55°C and reacted for 3-4 days; preferably, the molar ratio of compound 21 to Hoveyda-Grubbs II is 1:0.3-0.

7.

6. The preparation method according to claim 3, characterized in that, It also includes the step of preparing compound 9 according to the following reaction route; 。 7. The synthesis method as described in claim 6, characterized in that, in Under anhydrous and oxygen-free conditions, compound 11 reacts with TESCl to protect the hydroxyl group. Then, under anhydrous and oxygen-free conditions and with ZrCp2Cl2 and AlMe3 forming a catalyst, the hydroxyl-protected intermediate is reacted with ethyl chloroformate at room temperature for 12-14 hours to obtain the intermediate product. Then, under anhydrous and oxygen-free conditions and at -80 to -75°C, the intermediate product was mixed with DIBAl-H for 55 to 65 minutes, and then the temperature was raised to -65 to -55°C for 1.5 to 2.5 hours to obtain compound 12. Alternatively, under anhydrous and oxygen-free conditions at 0-5°C, compound 12 is mixed with imidazole, then TBSCl is added and the mixture is heated to room temperature and reacted for 12-14 hours to obtain a silicon-protected intermediate; under anhydrous and oxygen-free conditions at 0-5°C, the silicon-protected intermediate is reacted with PPTS for 2-3 hours to obtain compound 13. Alternatively, under anhydrous and oxygen-free conditions and at -80 to -75°C, add dropwise to compound 13. n BuLi was heated to room temperature for 4-4.5 hours, then ICH2CO2Na was added and reacted for 48-50 hours to obtain a carboxylic acid intermediate. Under anhydrous and oxygen-free conditions at -80 to -75°C, Et3N and PivCl were added dropwise to the carboxylic acid intermediate, mixed thoroughly, and then heated to room temperature for 55-65 minutes to obtain an activated carboxylic acid intermediate. Under anhydrous and oxygen-free conditions at -80 to -75°C, [the following steps were performed]. n BuLi was added dropwise to the carboxylic acid activation intermediate, mixed under heat, and then the temperature was gradually increased to room temperature for 12-14 hours to obtain compound 14. Alternatively, under anhydrous and oxygen-free conditions and at -80 to -75°C, Et3N was added sequentially to compound 14. n After Bu2B·OTf is mixed evenly, it is heated to 0~5℃ and reacted for 2~2.2 hours. Then it is cooled to -80~-75℃ and CH3CHO is added dropwise. After mixing evenly, it is heated to -22~-18℃ and reacted for 14~16 hours to obtain compound 15. Alternatively, under anhydrous and oxygen-free conditions at 0–5°C, compound 15 is mixed with imidazole and TBSCl, heated to room temperature, and reacted for 14–16 hours to obtain a silicon-protected intermediate; under anhydrous and oxygen-free conditions at 0–5°C, NaBH4 solution is added dropwise to the silicon-protected intermediate, heated to room temperature, and reacted for 14–16 hours to obtain a hydroxyl intermediate; under anhydrous and oxygen-free conditions at 0–5°C, the hydroxyl intermediate is mixed with NaHCO3 and DMP, heated to room temperature, and reacted for 3–4 hours to obtain compound 16. Alternatively, under anhydrous and oxygen-free conditions and at -80 to -75°C, add diethyl allylphosphonate dropwise. n BuLi, then add compound 16 and HMPA, mix for 110-130 minutes, heat to room temperature and react for 14-16 hours to obtain compound 17; Alternatively, under anhydrous and oxygen-free conditions at 0-5°C, compound 17 is reacted with p-toluenesulfonic acid for 2-3 hours to obtain a desilication intermediate; under anhydrous and oxygen-free conditions at 0-5°C, the desilication intermediate is mixed with NaHCO3 and DMP, and the mixture is heated to room temperature for 1-1.5 hours to obtain an aldehyde intermediate; under anhydrous and oxygen-free conditions at room temperature, the aldehyde intermediate is mixed with 3-methyl-1-butene, NaClO2, and NaH2PO4, and the mixture is reacted for 4-5 hours to obtain compound 9.

8. The preparation method according to claim 3, characterized in that, It also includes the step of preparing compound 10 according to the following reaction route; 。 9. The synthesis method as described in claim 8, characterized in that, in Compound 13 was mixed with DCC, DMAP and 2,4-pentadienoic acid under anhydrous, oxygen-free and room temperature conditions, and reacted for 14-16 hours to obtain compound 18. Alternatively, under anhydrous, oxygen-free, and room temperature conditions, compound 18 is mixed with TBAF and reacted for 2-3 hours to obtain a desilication intermediate; under anhydrous, oxygen-free, and 0-5°C conditions, the desilication intermediate is mixed with NaHCO3 and DMP and reacted at room temperature for 2-3 hours to obtain an aldehyde intermediate; under anhydrous, oxygen-free, and room temperature conditions, the aldehyde intermediate is mixed with 3-methyl-1-butene, NaClO2, and NaH2PO4 and reacted for 4-5 hours to obtain compound 10.

10. An intermediate, characterized in that, Its chemical structure is: 。